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Abstract
THE ROLE OF CA2+/CALMODULIN DEPENDENT PROTEIN KINASE II, CaMK-II, IN
KIDNEY MORPHOGENESIS
By Sarah R. Ingram, B.A.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2020
Robert M. Tombes, Ph.D.
Vice Provost, Life Sciences
Sarah C. Rothschild, Ph.D.
Assistant Professor, Life Sciences
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common
heritable diseases in the world, characterized by the development of large fluid filled cyst that
inhibit kidney function. Treatments for this disease are currently limited due to a lack of
understanding of disease pathogenesis. Ca 2+/calmodulin dependent protein kinase II (CaMK-II) is
necessary for kidney morphogenesis in zebrafish as well as being a downstream effector of pkd2,
one of the genes most commonly mutated in ADPKD patients. The roles of CaMK-II during
zebrafish kidney development include regulation of cell migration and pronephric convolution, as
well as cloacal cilia stability. The influence of CaMK-II on these pathways is partially dependent
on its regulation of HDAC4 localization. Inhibition of CaMK-II caused the translocation of
HDAC4 from its location in the cytosol to the nucleus. This led to the model that CaMK-II
activation via PKD2 retains HDAC4 in the cytosol allowing for transcription of its target genes.
Notch signaling proteins were also identified to be potential members of this pathway as inhibition
of CaMK-II caused a reduction in notch signaling in the cloaca as well as an increase in expression
of the notch ligand deltaC. This increase in deltaC expression in embryos with inhibited CaMKII was rescued by suppression of hdac4. Further studies attempted with a zebrafish camk2g1

xvi

mutant proved inconclusive as mutants displayed none of the phenotypic defects seen in morphant
embryos. Analysis of CaMK-II gene expression in camk2g1 mutants identified the capability of
genetic compensation between CaMK-II isoforms. In camk2g1 mutants, the paralog gene camk2g2
is upregulated over 3 fold, compensating for the loss of its paralog gene, thereby preventing the
phenotypic defects typically seen in camk2g1 morphants. This compensation is not immediate as
upregulation of camk2g2 was not seen in G0 camk2g1 CRISPR embryos. In conclusion, this study
has not only furthered the understanding of the roles of CaMK-II during kidney development and
identified new potential therapeutic targets for ADPKD patients, but it has also demonstrated the
ability of CaMK-II isoforms to compensate for one other. In addition to providing a greater
understanding of the relationship between CaMK-II paralogs, this study also further validates the
uses of knockdown methods in developmental studies as compensation was found not to occur in
these models.
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Chapter 1: Background

Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common
heritable diseases in the world (Igarishi and Somlo, 2002). In spite of its prevalence, no specific
treatments exists due to a lack of understanding of its pathogenesis (Igarishi and Somlo, 2002).
ADPKD is characterized by the development of large fluid-filled kidney cysts that gradually
enlarge over time and replace healthy renal tissue (Igarishi and Somlo, 2002) (Kottgen, 2007).
Cystic development can also occur in other organs such as the pancreas, liver, spleen, and ovaries
(Gabow, 1993). This disease is thought to affect anywhere from 1 in 400 to 1 in 1000 individuals
and is the fourth leading cause for renal replacement worldwide (Ong et al., 2015).
Initiation of cyst development in ADPDK patients requires a primary germline mutation in
genes PKD1 and/or PKD2, as well as a secondary somatic mutation in either PKD1/PKD2 (Igarishi
and Somlo, 2002). A PKD3 gene has been proposed in order to account for patients lacking
mutations in PKD1 or PKD2 (Porath et al., 2016). A candidate for this gene is GANAB, which
encodes for glucosidase II subunit α (Porath et al., 2016). Mutations in this gene have been shown
to cause mild ADPKD and mild to severe autosomal dominant polycystic liver disease (ADPLD)
(Porath et al., 2016). However, mutations in GANAB only account for 3% of unresolved cases,
implying that other genes are involved in ADPKD development in patients without mutations in
PKD1 and PKD2 (Porath et al., 2016).
PKD1 codes for polycystin-1, a conserved membrane protein that is able to interact with
a variety of other proteins such as lipids and carbohydrates (Wilson, 2006). PKD1 contains
domains known to be involved in cell-cell and cell/matrix interactions (Chauvet et al., 2002).
Expression of PKD1 can be seen in human fetal tissue samples in the neural tube, cardiomyocytes,
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mesonephros, and endodermal derivatives (Chauvet et al., 2002). PKD1 expression can also be
seen in differential proximal tubules during nephron development. Although many of the roles of
PKD1 are still being elucidated, it is thought to have roles in transcription factor activation, Gprotein binding, regulation of Wnt signaling, as well as regulation of proliferation and resistance
to apoptosis (Parnell et al., 1998) (Arnould et al., 1998) (Kim et al., 1999) (Boletta, 2000).
Approximately 85% of ADPKD cases are caused by mutations in PKD1 (He et al., 2011).
These mutations can occur in a variety of forms including nonsense mutation, frame shift
mutations, missense mutations, and aberrant splicing (He et al., 2011). It is thought that patients
with mutations in the 5’ regions suffer from a more severe form of ADPKD than those with
mutations in the 3’ region (He et al., 2011). Homozygous knockout of Pkd1 in mice causes severe
renal cyst development and death by embryonic day 15 (He et al., 2011). Heterozygous mutants
for Pkd1 are viable. However, they still exhibit renal and hepatic cyst development (He et al.,
2011) (Piontek et al., 2004). Loss of Pkd1 also causes other defects in mice including
cardiovascular and skeletal defects (Boulter et al., 2001) (Kim et al., 2000).
PKD2 encodes for polycystin-2 (TRPP2), a member of the TRP family of Ca 2+ ion channels
(Chauvet et al., 2002). PKD1 forms a complex with PKD2 enabling the formation of a nonselective cation channel (Clapham 2003) (Mochizuki et al., 1996). In human tissue, PKD2 can be
found in the plasma membrane, endoplasmic reticulum, and the primary cilium and has various
functions depending on its location within the cell (Igarishi and Somlo, 2002) (Cai et al., 1999).
In the plasma membrane, when complexed with PKD1, PKD2 functions as a non-selective cation
channel with a higher selectivity for Ca 2+ (Hanaoka et al., 2000) (Tsiokas et al., 2007). In the
endoplasmic reticulum, PKD2 functions as an intracellular Ca 2+ channel that is activated in
response to alterations in intracellular Ca 2+ levels (Cai et al., 1999) (Tsiokas et al., 2007). In the
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primary cilium, PKD2 acts as a regulator of intracellular Ca 2+ in response to fluid flow (Tsiokas et
al., 2007) (Praetorius and Spring 2001). PKD2 has also been found in the mitotic spindle and
centrosomes (Tsiokas et al., 2007). Although its exact function at these locations is not completely
known, it is thought that it could be responsible for regulating Ca 2+ levels during cell division
(Rundle et al., 2004).
Mutations in PKD2 account for approximately 15% of ADPKD cases (He et al., 2011).
Typically, patients with mutations in PKD2 have a smaller number of cysts and don’t exhibit other
symptoms until later in life. However, patients with mutations in PKD2 still suffer from a high
frequency of renal failure with advanced age (Stypmann et al., 2007) (Hateboer et al., 2007).
Homozygous and heterozygous mouse mutants for Pkd2 develop cysts in the kidneys and liver
(Wu et al., 1998). In addition to cyst development, mouse mutants for Pkd2 also exhibit loss of
left-right asymmetry, defects in reproductive tract development, and cardiovascular defects, a
condition often seen in patients (Kuol et al., 2016) (Wu et al., 2000) (Pennekamp 2002) (Nie et al.,
2014).

Zebrafish (Brachydanio rerio) as a Model Organism
The use of Brachydanio rerio, more commonly known as zebrafish, as a model organism
originated in the 1970s with the work of George Streisinger. Zebrafish are a small freshwater
cyprinoid fish that is thought to have originated in India, and can now be commonly found in pet
stores around the world. Streisinger and his colleagues recognized the advantages of using
zebrafish as a model for developmental and genetic studies, including their short generation time,
high fecundity, external fertilization, and transparency during development (Streisinger et al.,
1981). Through their work using zebrafish, Streisinger and his lab were able to develop protocols
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for using zebrafish for a variety of applications including cloning (Streisinger et al., 1981),
mutagenic studies (Grunwald et al., 1988) and cell lineage tracing (Streisinger et al., 1988).
Since the work of Streisinger and his lab, zebrafish have become a staple in scientific
research around the globe. The Sanger Institute started the zebrafish genome sequencing project
in 2001 and has since created a full reference genome. (Howe et al., 2013). Zebrafish contain 25
chromosomes (Postlethwait et al., 2000) and the zebrafish genome is thought to contain 26,206
protein-coding genes (Howe et al., 2013). Of those protein-coding genes, approximately 70% are
believed to have a human orthologue (Howe et al., 2013). The similarities between human and
zebrafish genomes make the zebrafish a unique and essential tool for human medical research.
Zebrafish provide an excellent model to study kidney development due to common cell
types and molecular pathways as well as their transparency during early development (Drummond
and Davidson, 2010). During embryogenesis, zebrafish possess a pronephric kidney which
consists of two pronephric ducts fused at the proximal end with the glomeruli and fused at the
distal end with the cloaca (Drummond and Davidson, 2010). In zebrafish, kidney cells are
specified from the intermediate mesoderm at approximately 18hpf. The cells then undergo
epithelialization at approximately 24hpf before migrating anteriorly via collective cell migration
where they turn inward to connect with the glomerulus (Drummond and Davidson, 2010)
(Vasilyev et al., 2009) This turning inward to connect with the glomerulus is known as ductal
convolution and is thought to result from the piling up of cells at the anterior end (Vasilyev et al.,
2009). Angiogenesis then occurs and the pronephros are fully functional by 48hpf (Drummond
and Davidson, 2010).

5

Zebrafish Models of Polycystic Kidney Disease
Zebrafish have proven to be a useful model for ADPKD caused by mutations in both pkd1
and pkd2. Zebrafish models for pkd1 loss of function exhibit many defects in development.
Inhibition of zebrafish paralogs pkd1a/pkd1b caused alterations in extracellular matrix proteins,
hydrocephaly, craniofacial defects, and pronephric cyst development in a low percentage of
embryos (10-15%) (Mangos et al. 2010). Zebrafish with a loss of pkd1 also showed lymphatic
system defects and cardiac edema by 5 days post fertilization (Coxam et al., 2014).
Zebrafish models of ADPKD resulting from loss of pkd2 expression have also proven to
be a valuable tool in understanding disease traits and progression. Like other models,
downregulation of pkd2 results in the development of kidney cysts and defects in left-right
asymmetry (Mangos et al., 2010) (Obara et al., 2006) (Schottenfeld et al., 2007). Other defects
seen in zebrafish with a loss of pkd2 include hydrocephaly as well as body curvature, which is
thought to result from alterations in the extracellular matrix (Mangos et al., 2010) (Obara et al.,
2006). Zebrafish injected with pkd2 mRNA that lack either the C-terminus or N-terminus
dimerization domain also resulted in the formation of kidney cysts (Feng et al., 2008).

Calcium Calmodulin Dependent Protein Kinase II (CaMK-II)
CaMK-II is a serine/threonine protein kinase encoded by four genes in eukaryotes (α, β, γ,
δ) (Tombes et al., 2003). CaMK-II forms oligomers of up to 12 subunits of which the subunits can
be the same or different isomers (Bayer and Schulman, 2019). Each monomer of the holoenzyme
consists of a catalytic, variable, and association domain (Tombes et al., 2003). The catalytic
domain is 315 amino acids in length and contains the CaM binding domain. The variable domain
can be between 30-100 amino acids in length and is subject to alternative splicing. The association
domain is 135 amino acids in length and is responsible for the oligomerization of the holoenzyme
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(Tombes et al., 2003). The formation of the holoenzyme brings catalytic heads into proximity,
facilitating the unique ability of CaMK-II to autophosphorylate at site T287. CaMK-II is activated
by the binding of Ca2+/CaM binding which relieves inhibition of the autoinhibitory arm, allowing
for phosphorylation of site T 287 (T286 in α). (Hudman and Schulman, 2002). The kinase is then
capable of autophosphorylating the other subunits of the holoenzyme allowing for it to remain up
to 80% activated after calcium stimulus has subsided (Tombes et al., 2003) (Rosenberg et al.,
2005).
CaMK-II is best known for its role in the central nervous system. It comprises over 1% of
total protein in the brain, where it is a known regulator of neuronal plasticity and cognitive function
(Bayer and Schulman, 2019). It is not only a key protein involved in long term potentiation, a
process correlated to the formation of memories, but has recently been identified as a regulator of
long term depression as well (Wang et al., 2013) (Hudman and Schulman, 2002) (Bayer and
Schulman, 2019). Mice lacking αCaMK-II, the predominate form of CaMK-II in the brain, showed
diminished long term potentiation in the hippocampus (Hinds et al., 1998). Conversely, mice that
overexpressed activated CaMK-II had impaired context discrimination (Ye et al., 2019). These
studies along with many others over the years have demonstrated the importance of CaMK-II in
the brain.
In addition to its roles in the brain, CaMK-II has also been shown to be present in almost
every tissue and is involved in a large variety of processes throughout the body (Tombes et al.,
2003). CaMK-II is involved in Ca2+ regulation in the heart as well as heart morphogenesis (Maier
and Bers, 2002) (Rothschild et al., 2009). It also has a role in regulating cell motility by inducing
de-phosphorylation of focal adhesion proteins thereby promoting focal adhesion turnover. (Easley
et al., 2008). CaMK-II is also involved in left-right asymmetry in vertebrates as well as the
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development of neurons in the enteric nervous system (Langerbacher and Chen, 2008)
(Francescatto et al., 2010) (Gao et al., 2012).

CaMK-II as a PKD2 Target
Using zebrafish as a model organism, CaMK-II was determined to be required for kidney
morphogenesis (Rothschild et al., 2011). CaMK-II is encoded by 7 genes in zebrafish (α, β1, β2,
γ1, γ2, δ1, δ2) and is expressed throughout the embryo (Rothschild et al., 2011) (Rothschild et al.,
2009). CaMK-II can be seen in the developing kidney beginning at 24hpf and is concentrated in
the apical regions (Rothschild et al., 2011). Later, it can be seen throughout the pronephros at
30hpf at apical and basolateral cell surfaces as well as in intracellular clusters (Rothschild et al.,
2011). Autophosphorylated CaMK-II is also present in the cloacal cilia at 30hpf (Rothschild et al.,
2011). Camk2g1 was shown to be the predominant form of CaMK-II present in the kidney
(Rothschild et al., 2011).
Camk2g1 expression was suppressed in zebrafish embryos using a translation blocking
antisense morpholino oligonucleotide (camk2g1 MO), causing defects in kidney development
along with several other deformities (Rothschild et al., 2011). These defects include pronephric
cyst development, hydrocephaly, loss of left-right asymmetry, and body curvature (Rothschild et
al., 2011) (Francescatto et al., 2010). Inhibition of camk2g1 also caused a decrease in the distance
kidney cells migrated during development (Rothschild et al., 2011). These cells were unable to
undergo anterior convolution, preventing them from connecting with the glomerulus (Rothschild
et al., 2011).This inhibition of kidney function was also demonstrated using a renal filtration assay
showing a lack of fluid excretion over a 16 hour time period (Rothschild et al., 2011).
Inhibition of camk2g1 caused specific defects in the distal region of the pronephric ducts.
Pronephric occlusions were seen in the distal portion at 3dpf in 73% of morphants embryos. In

8

addition, cloacal cilia formed normally in camk2g1 morphants at 24hpf, but by 48hpf they had
begun to destabilize, causing a reduction the number of cloacal cilia present from 13 in wild type
embryos to one in camk2g1 morphants. The remaining cloacal cilia present in morphant embryos
were found to be shorter and immotile (Rothschild et al., 2011).
A predominant defect seen in camk2g1 morphants was cyst development (Rothschild et
al., 2011). This could be seen using both a camk2g1 morpholino and a dominant negative (DN)
form of CaMK-II (K43 A) which lacks phosphotransferase ability. These defects in kidney
development, as well as other associated defects like body curvature and hydrocephaly, mimic the
phenotype of zebrafish embryos with inhibited pkd2 expression (Mangos et al., 2010)
(Schottenfeld et al., 2007) (Feng et al., 2008) (Rothschild et al., 2011). This led to the model that
Ca2+ entry via pkd2 enables activation of CaMK-II which in turn influences kidney development
by regulating cellular migration, pronephric convolution, and cloacal cilia stability (Rothschild et
al., 2011). This model was supported by the co-injection of the morpholino for pkd2 and a
constitutively active (CA) form of CaMK-II (T287D) which was able to rescue anterior migration
and kidney convolution as well as reduce pronephric occlusions and hydrocephaly (Rothschild et
al., 2011).
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Chapter 2: Calcium Signals Act through Histone Deacetylase to Mediate Pronephric
Kidney Morphogenesis

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common heritable disease
the world, occurring in approximately 1-400 to 1-1000 live births. This disease, characterized by
the development of large fluid filled cyst, is caused by mutations in genes PKD1 and PKD2. PKD2
is a TRP cation channel necessary for Ca 2+ entry and activation of CaMK-II, a serine/threonine
protein kinase required for kidney morphogenesis and cilia stability. In an effort to further
elucidate the molecular pathways involved during kidney morphogenesis as well as identify
potential therapeutic targets for ADPKD patients, the role of class II HDACs present during kidney
morphogenesis was evaluated as well as their relationship with camk2g1, the predominate form of
CaMK-II present in the pronephros. Class II HDAC family members (HDAC4, 5, and 6) were
suppressed using antisense morpholino oligonucleotides and pharmacological inhibitors. While
inhibition of hdac6 caused no gross morphological defects, inhibition of hdac5 resulted in the
development of anterior kidney cysts and destabilized cloacal cilia, mimicking the phenotype of
both pkd2 and camk2g1 morphants. Inhibition of hdac4 caused elongated cloacal cilia when
compared to control embryos. The reduction of hdac4 or hdac5 activity in camk2g1 morphants
caused opposing results. Suppression of hdac4 in embryos with reduced camk2g1 activity rescued
cilia shorting and ductal convolution defects while suppression of hdac5 caused severe branching
of the pronephros and a significant loss of pronephric cell migration. Further investigation into the
relationship between class II HDACs and CaMK-II revealed that inhibition of camk2g1 caused a
translocation of hdac4 from the cytosol into the nucleus. The subcellular localization of hdac5 was
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unaffected by the loss of camk2g1 activity. These results suggest a role for CaMK-II in retaining
HDAC4 in the cytosol, enabling primary cilia formation and anterior kidney morphogenesis.
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Introduction

Histone Deacetylases
Histone deacetylases (HDACs) are conserved enzymes that catalyze the removal of an
acetyl group from lysine residues. This most commonly occurs on histones, where removal of the
acetyl group condenses the chromatin structure, preventing transcription of target genes (Seto and
Yoshida 2014). Histone deacetylases also have a variety of non-histone targets where they act to
regulate a number of cellular processes. These processes include ubiquitination and degradation
of p53, deacetylation of α-tubulin, and regulation of cell motility (Luo et al 2000) (Hubbert et al
2002) (Di Giorgio et al 2013). The wide range of HDAC target was demonstrated using pan HDAC
pharmacological inhibitors which caused in increase in acetylation in 10% of over 3500 tested
acetylation sites (Choudhary et al 2009).
Histone deacetylases are divided into four classes based upon sequence similarity. Class I
HDACs include HDACs 1, 2, 3, and 8. Class II consists of HDACs 4, 5, 6, 7, 9, and 10. Class IV
consists of HDAC11 (Seto and Yoshida, 2014). These three classes are all part of the
arginase/deacetylase superfamily whose targets include both histone and non-histone proteins.
Class III consists of NAD+ dependent proteins SIRT 1-7 and belongs to the Sir2 regulator family
which is involved in transcription silencing (Seto and Yoshida, 2014) (Brachmann et al., 1995).
Histone deacetylases are known to have roles in a variety a human diseases, making them
an important candidate for therapeutic treatments (Seto and Yoshida, 2014). HDACs are associated
with a variety of cancers and increased levels are associated with poor prognosis in ovarian and
endometrial cancers (Li and Seto, 2016) (Weichert et al, 2008). In other types of cancers, such as
melanoma and lung cancer, it is the loss of HDAC activity that is associated with poor prognosis.
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(Li and Seto, 2016). Although their roles in various cancers may be complex, the use of selective
and non-selective HDAC inhibitors have proven effective in the treatment of a number of cancers
with over 20 pharmacological inhibitors being used in clinical trials (Li and Seto, 2016). HDAC
inhibitors have also been successful in treating Alzheimer’s disease, where suppression of Hdac2
resulted in increased synaptic plasticity and memory formation in mouse models (Graff et al.,
2012). HDACs have also been implicated in lung disease, cardiac abnormalities and a number of
other disease making them an important topic of studies for treatment of human conditions (Seto
and Yoshida 2014).
Class II HDACs and CaMK-II
Class II HDACs regulate MEF2C gene transcription, genes that encode for Ca 2+ dependent
mediators of transcription (McKinsey et al, 2002). Interestingly, Mef2c knockout mice develop
kidney cysts, mimicking the phenotype of both Pkd2 knockout mice and γ1 CaMK-II inhibited
zebrafish (Xia et al., 2010) (Wu et al., 1998) (Rothschild et al., 2011). Interestingly,
downregulation of HDACs in Pkd2 mutant mice have been able to inhibit cyst development (Xia
et al, 2010). Two specific class II HDACs have a unique relationship with CaMK-II. HDAC4
possesses a CaMK-II specific docking site allowing it be directly phosphorylated by CaMK-II.
This causes its translocation from the nucleus to the cytosol in muscle tissue (Backs et al, 2006)
(Little et al 2007).
CaMK-II is also able to affect the localization of HDAC5 through direct interaction with
HDAC4 (McKinsey et al, 2002). While HDAC5 does not possess a specific binding site for
CaMK-II, it is able to hetero-oligermerize with HDAC4 through their respective coil-coiled
domains. This allows for HDAC5 to become responsive to CaMK-II in two different way. One
being by bound to HDAC4 while it is interacting directly with CaMK-II. The second way by a
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transphosphorylation event when interactions between HDAC4 bringing it into close proximity to
CaMK-II (Backs et al., 2008). The ability of CaMK-II to directly affect the subcellular localization
of specific class II HDACs combined with their previously studied role in kidney cyst development
in mice demonstrate a potential role for class II HDACs in polycystic kidney disease pathology.
Through the model organism zebrafish, this study further explains the roles of HDACs during
kidney development as well as demonstrates interactions between class II HDACs and CaMK-II,
a protein known to be affected in zebrafish ADPKD models (Rothschild et al, 2011).
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Methods and Materials

Zebrafish Strains and Care
Zebrafish embryos were obtained though natural matings and raised at 28.5°C (Kimmel et al,
1995). Zebrafish strains used were Wild-type (AB and WIK), Tg(atp1a1a.5:EGFP), and
Tg(cmlc2:EGFP)

Fluorescent Localization
Embryos were fixed in 4% paraformaldeype or Dent’s fixative as previously described (Rothschild
et al., 2011). Embryos were then incubated with one of the following primary antibodies: rabbit
anti-acetylated histone H3 (Millipore [06-599] at 2.5 µg/ml), mouse anti‐acetylated α‐tubulin
(Sigma Chemical Co. [T7451] at 2 μg/ml), or mouse anti‐α 1 Na+/K+‐ATPase (Developmental
Studies Hybridoma Bank, University of Iowa [α6F] at a 1:10 dilution). Embryos were incubated
overnight in primary antibody after which they were placed with one of the following secondary
antibodies: goat anti‐mouse Alexa488 or goat anti‐rabbit Alexa568 (Invitrogen at 2.5 μg/ml). In order
to analyze craniofacial development, embryos were incubated overnight at 4°C with rhodamine
phalloidin (Life Technologies, 1:1000). Embryo heads were then dissected and mounted on
chamber slides, and imaged using confocal microscopy. Embryos were imaged either on a Nikon
E600 compound microscope using a 20X dry, 40X dry, or 100X oil immersion objective, or on
Nikon AZ‐100 Macro Zoom fluorescent stereo microscope.
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Morpholino Injections
Translation-blocking antisense morpholinos were designed to target zebrafish camk2g1 (1ng),
hdac4 (2ng), hdac5 (2ng), and hdac6 (8ng) and were purchased from Gene Tools along with a
control mismatch morpholino (2ng). All morpholinos were used as previously described with an
injection volume of 1nl (Francescatto et al., 2010) (Rothschild et al., 2011) (Rothschild et
al., 2013). The morpholinos for hdac4, hdac5, and hdac6 were designed to target the following the
regions around the translation start site: hdac4: CGCCACACTCACATCAACCATCAGC;
nucleotides ‐11 to + 14), hdac5: GATCTTCCCTGCCTGAAGTTCTCCA; nucleotides ‐38 to ‐14),
hdac6: TTTGGTATCTGGAACCGCATCCATC; nucleotides ‐5 to + 20)

cDNA Injections
Wild type zebrafish embryos were collected and RNA was extracted using TRIzol (Invitrogen) at
1, 6, 19, 24, 48, and 72 hours post fertilization. cDNA was generated using SuperScript III. Hdac4
(sense:5′-CCAAAGATGACTTCCCGCTCCGC-3′, antisense:5′-GAGGCTCTTGTTTAATGGT
GACC-3′), hdac5 (sense:5′-GGAACACCACCCTCCTACAAACTCC-3′, antisense:5′GGAGG
CTGTCTTGGAAGATCCGTCCC-3′), and hdac6 (sense:5′-CCGCTTTGACTGCACGCTA
TGC-3′, antisense: 5′- CTAAGAGAGCTCCAGAAGGGGGCGTG-3′) were amplified using
High Fidelity Taq (Invitrogen). Amplified products were then cloned into the StrataClone vector
(Agilent), and sequenced as previously described (Rothschild et al., 2007).
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Whole Mount In Situ Hybridization
Digoxigenin‐labeled antisense riboprobes were synthesized as previously described using T3 or
T7 RNA polymerase (Rothschild et al., 2007). Embryos used for whole‐mount in situ
hybridization

(WISH)

were

developed

using

alkaline

phosphatase–conjugated

anti‐

digoxigenin. Probes for Hdac4, hdac5, and hdac6 were designed to correspond to sequences
amplified using the primer sets listed above. Cdh17, pax2a, and cmlc2 probes were prepared as
previously described (Wingert et al., 2007; Wingert and Davidson, 2008).

Mouse HDAC5 Expression Vector
The murine hdac5 ORF was purchased from GE/Dharmacon (Clone ID: 5720438) and PCR‐
amplified using the following primers: Sense: 5′ GCGTCCGGAATGAACTCTCCCAACGAGT
CGG 3′; Antisense: 5′ CGCTCTAGAGGGATGGGGGCCAGGGTGTCACAG 3′. It was then
digested with BspEI and XbaI, and cloned into the pEGFP‐C1 vector with N‐terminal EGFP.
This hdac5 construct was injected at the one cell stage into zebrafish embryos at a concentration
of 30 ng/µl. The murine hdac4 was a gift from Dr. Eric N. Olson and was injected at 30 ng/μl at
the one cell stage (Backs et al., 2006). HDAC4 and HDAC5 localization was assessed in live
embryos at 24–48 hpf.

Zebrafish HDAC4 Expression Vector and mRNA Synthesis
Zebrafish HDAC4 was PCR-amplified (CGCGGATCCCATGACTTCCCACAGCCGTCCAG,
GCGCTCGAGGATGGAGAGATTAGAGGGACATCAG) from 24hpf cDNA and cloned into
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the pCRII-TOPO vector (Invitrogen). HDAC4 was cloned into the Gateway middle entry vector
using BamHI and Xhol. Cherry was amplified (CCAAGCTTATGGTGAGCAAGGGCGAGGA
GG, GGATCCCGCGCTTGTACAGCTCGTCCATGCC), digested with HindIII and BamHI, and
ligated into HDAC4 entry vector. This vector was cloned into the final Gateway vector with the
5’ Sp6 pEntry vector and 3’ poly A entry vector. The construct was linearized using SpeI and
mRNA was generated using the Sp6 mMessage kit (Thermo)

HDAC Rescue
Hdac4 MO (2ng) and hdac4 RNA (100ng) were co-injected or sequentially injected into zebrafish
embryos at the one cell stage. Embryos were assessed at 24hpf to assess left-right asymmetry.
Embryos were fixed at 72hpf, labeled with mouse anti-acetylated α-tubulin in order to assess cilia
length and number, and imaged using confocal microscopy.
Hdac4 MO (2ng) was injected into zebrafish embryos at the one cell stage alone or co-injected
with mouse EGFP-HDAC5 (30ng/µl). Left-right asymmetry was assessed at 24hpf. At 72hpf,
embryos were fixed and labeled with mouse anti-α1 Na+/K+-ATPase. Embryos were then
analyzed for ductal convolution and anterior cell migration using confocal microscopy.

Drug Treatment
Zebrafish embryos were incubated in 0–200 nM TSA or 0–10 μM tubastatin A in 3 ml of system
water starting at cleavage stage and continuing until fixing. Rescue experiments were performed
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by continuously incubating camk2g1 morphants embryos with 100 nM TSA beginning at bud stage
until being fixed.

Generation of Nuclear and Cytosolic Targeted HDAC Constructs
Point mutations were generated on the previously used EGFP-HDAC5 and Cherry-HDAC4
expression constructs using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies
#200519). The mutated sites for HDAC4 were S458A, S606A, S458D, and S606E. The mutated
sites for HDAC5 were S251A, S480A, S251D, and S480D.

The construct was sequenced to

confirm the mutation was achieved as well as to confirm no additional mutations were present.
Products were then purified and transformed as previous described (Rothschild et al, 2011).

Video Microscopy
Live embryo cilia videos were obtained using DIC optics on a Nikon 60X water‐immersion Plan
APO objective and 20‐frames‐per‐second acquisitions. Embryos were anesthetized and
immobilized as previously described (Rothschild et al., 2011).

Statistical Analysis
Statistical significance was set at P<0.005 using the two-tailed t-test
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Results

Expression of Class II HDAC 4, 5, and 6 are Detected in Zebrafish Embryos
Throughout Early Development
Three Class II HDACs were evaluated for their effects on early development based upon
their previously established roles in relation to CaMK-II and kidney development. HDAC4 is
known to be CaMK-II responsive in muscle tissue as well as possess a specific CaMK-II docking
site (Di Giorgio and Brancolini, 2016). HDAC5 has also been shown to be responsive to CaMKII, however only in the presence of HDAC4 (Backs et al., 2008). In contrast to other HDACs,
HDAC6 deacetylates tubulin over histones and suppression of HDAC6 caused a reduction in cyst
formation in mouse models of cystic kidney disease (Cebotaru et al., 2016; Li et al., 2016; Yanda
et al., 2017a; Yanda et al., 2017b).
Expression of hdac4, hdac5, and hdac6 can be seen using both semiquantitative reverse
transcription-polymerase chain reaction (RT-PCR) as well as in situ hybridization (Figure 2.1 UZ). Transcript levels for all three genes were seen throughout development, from maternal
transcripts through to 72hpf. All three transcripts were also able to be amplified from isolated
kidneys at 24hpf. Hdac4 and hdac6 mRNA were also able to be amplified from isolated heart
tissue at 36 hpf (Figure 2.1 U-W).

Inhibition of Specific Class II HDACs Causes Defects in Early Development
In order to evaluate the roles of HDAC4, HDAC5, and HDAC6 in early development,
translation blocking antisense morpholinos were designed for each, and injected into zebrafish
embryos at the 1-4 cell stage. Tail curvature defects can been seen in all three morphants at 24 hpf
when compared to control embryos (Figure 2.1 A-D). These defects were persistent and could be
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seen at 48hpf and 72hpf in all three morphants (Figure 2.1 E-L). Previous studies indicated a role
for hdac4 in craniofacial development in zebrafish embryos. Similarly, craniofacial defects,
including clefting were observed in hdac4 morphants at 72hpf, consisted with previously published
data (DeLaurier et al., 2012) (Figure 2.1 M,N).
The effectiveness of the hdac4 and hdac5 morpholinos were assessed by examining the
levels of acetylated histone 3 in morphant embryos at 48hpf. Acetylated histone 3 levels were
elevated in morphants when compared to controls demonstrating a decrease in levels of hdac4 and
hdac5 activity. The effectiveness of the hdac6 morpholino was examined by observing acetylation
levels in α-tubulin in lateral line axons and in the brain in hdac6 morphants and control embryos.
Hdac6 morphants show an increase in acetylation levels in α-tubulin when compared to control
embryos demonstrating a decrease in hdac6 levels in morphants embryos (Figure 2.1 O-T )
At 48hpf, hdac4 and hdac6 morphants exhibited no defects in kidney morphology.
However, hdac5 morphants exhibited kidney cyst in the anterior portion of the pronephric ducts
near the glomerulus (Figure 2.2 A-D). This mimics cyst development seen in both camk2g1
morphants and pkd2 morphants (Rothschild et al., 2011). This cyst development could be
associated with lack of ductal convolution in these embryos. Ductal convolution is the turning
inward of the two pronephric ducts in order to connect with the glomerulus. When ductal
convolution was assessed in all three morphants, there was an absence of convolution in 80% of
hdac5 morphants. In contrast, only 15% of hdac4 morphants and 3% of hdac6 morphants failed to
convolution (Figure 2.2 E-M, p<.005). This lack of convolution could be caused by a decrease in
the distance pronephric cells migrate during development. This distance of cell migration can be
examined by measuring the distance from the base of the ear and the top of the kidney at 72hpf
(Rothschild et al, 2011). Compared to control embryos, the distance between the ear and the kidney
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was significantly increased in hdac5 morphants and unchanged in hdac4 and hdac6 morphants
(Figure 2.2 N, p<.005).
Inhibition of Class II HDACs Disrupts Primary Cloacal Cilia
Cilia are present in the zebrafish pronephros in both the ducts and the cloaca. Ductal cilia
are approximately 9µm in length and are derived from both mono- and multi-cilia. Cloacal cilia
are primary cilia that are shorter at approximately 3µm in length and rotate (Kramer‐Zucker et
al., 2005) (Sarmah et al., 2007) (Rothschild et al., 2011). In both pkd2 and camk2g1 morphants,
cloacal cilia is disrupted while ductal cilia is unaffected (Rothschild et al, 2011). In hdac5
morphants, cloacal cilia is disassembled at 72hpf. Any remaining cloacal cilia in hdac5 morphants
were immotile and much shorter in length. Cloacal cilia were also affected in hdac4 morphants
though in an opposite way. Cloacal cilia were still able to rotate but were elongated to an average
length of 5µm in hdac4 morphants (Figure 2.3 A-F, p<.005). The length of cloacal cilia in hdac4
morphants could be rescued by a co-injection of the hdac4 morpholino and 100ng of cherry-hdac4
mRNA (Figure 2.3 F, p<.005). In order to assure that these defects were not caused by a lack of
specification of kidney cells, expression of cdh17 and pax2 (two early kidney markers) was
assessed and found to be normal in all morphants embryos (data not shown). Interestingly, no
defects were seen in cloacal or ductal cilia in hdac6 morphants (Figure 2.3 A-F).
Primary cilia were also shown to be disrupted in the organ of asymmetry in pkd2 and
camk2g1 morphants. The primary cilia in the organ of asymmetry, known was the Kupffer’s
vesicle (KV), get resorbed when PKD2 or CaMK-II is inhibited (Francescatto et al 2010). In order
to assess whether the KV was also affected in class II hdac morphants, cardiac asymmetry was
examined using cmlc2. In both hdac4 and hdac5 morphants cardiac asymmetry was lost at 24hpf.
However, it was unaffected in hdac6 morphants. This loss of asymmetry in hdac4 morphants could
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be recovered by co-injection of cherry-hdac4 mRNA and it could be partially recovered in hdac5
morphants by co-injection of mouse EGFP-HDAC5 (Figure 2.3 G-J). Primary cilia in the KV was
similarly disrupted as cloacal cilia in the hdac morphants. Hdac4 morphants showed slightly longer
cilia in the KV, while hdac5 morphants exhibited shorter cilia (Figure 2.3 K-N).

HDAC Inhibitors Cause Defects in Kidney Development Similar to HDAC Morphants
TSA is a pan HDAC inhibitor that is known to be effective at inhibiting class I, II, and IV
HDACs in zebrafish (Cao et al., 2009b; Bertrand, 2010; de Groh et al., 2010). Zebrafish embryos
treated with up to 200nM of TSA were viable and showed no defects in gross morphology.
However, both ductal convolution and kidney cell migration were both negatively affected with
TSA treatment similar to hdac5 morphants (Figure 2.4 E,F, p<.005). Embryos treated with TSA
also displayed a loss of left-right asymmetry and cloacal cilia were elongated in a similar manner
as hdac4 morphants (Figure 2.4 A-D). Embryos treated with tubastatin A and tubacin, a HDAC6specific inhibitor, showed no defects in left-right asymmetry or kidney morphogenesis, again
mimicking the phenotype of hdac6 morphants (Butler et al., 2010) (Figure 2.4 D-F).

Inhibition of HDAC4 in camk2g1 Morphants Partially Rescues Ductal Convolution
Epistatic interactions between CaMK-II and Class II HDACs were evaluated by coinjection of camk2g1 morpholino and either hdac4, hdac5, or hdac6 to evaluate whether the
phenotypic defects seen in camk2g1 morphants was exacerbated or rescued. Ductal convolution is
lost in embryos with inhibited camk2g1. However, suppression of hdac4 in camk2g1 morphants
partially restored ductal convolution. This was also seen with treatment of TSA (Figure 2.5 A-P).
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Interestingly, suppression of hdac5 in camk2g1 morphants exacerbated the morphants phenotype,
causing branching of the pronephric ducts. This branching is similar to what was observed when
embryos were injected with a kidney targeted dominant negative CaMK-II (Figure 2.5 A-P)
(Rothschild et al, 2011). It is of note that although co-injection of hdac4 MO and camk2g1 MO
partially rescued ductal convolution, cell migration was not rescued, indicated by an increase in
ear-kidney distance when compared to control embryos (Figure 2.5 Q). This suggest separate
mechanisms mediate ductal convolution and cell migration during kidney morphogenesis.

Suppression of HDAC4 in Camk2g1 Morphants Prevents Cilia Disassembly
Epistatic interaction between camk2g1 and class II HDACs were further evaluated by
assessing the effects of suppressed hdac4 and hdac5 on the cloacal cilia of camk2g1 morphants.
Inhibition of camk2g1 in zebrafish embryos causes disassembly of cloacal cilia (Rothschild et al.
2011). Suppression of hdac4 in camk2g1 morphants was able to prevent cilia disassembly in the
cloaca, increasing the average number of cloacal cilia from 1 to an average of 8 (Figure 2.6 A-F,
p<.005). The cloacal cilia in embryos co-injected with hdac4 MO and camk2g1 MO were similar
in length to control embryos (3µm) and fully functional (Figure 2.6 G, p<.005). These results were
also mimicked with TSA treatment (Figure 2.6 E-G, p<.005). Co-injection of hdac5 MO and
camk2g1 MO did not rescue cloacal cilia as the average number present in co-injected embryos
was 1 (Figure 2.6 A-F, p<.005). The remaining cilia that were present were shorter in length as
previously seen in camk2g1 morphants (Figure 2.6 G, p<.005).
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Subcellular Localization of HDAC4 is altered with CaMK-II Inhibition
CaMK-II is known to directly influence the subcellular localization of HDAC4 in muscle tissue as
well as influence the localization of HDAC5 in the presence of HDAC4 (Backs et al., 2006). To
determine how suppression of CaMK-II influences localization of HDAC4 and HDAC5, EGFPtagged HDAC4 and HDAC5 constructs were injected with and without the camk2g1 MO. Muscle
cells expressing the EGFP-tagged HDAC4 or HDAC5 show predominantly nuclear expression,
which remain unchanged with suppression of camk2g1 (Figure 2.7 A,B,E,F). This was the same
for pronephric cells expressing EGFP-tagged HDAC5, with expression being predominantly
nuclear with and without the presence of the camk2g1 MO (Figure 2.7 C,D). However, localization
of HDAC4 in pronephric cells was altered with suppression of camk2g1. Suppression of camk2g1
caused a shift in EGFP-HDAC4 localization from predominately nuclear to cytosolic. This suggest
a specific role of CaMK-II to retain HDAC4 in the cytosol during kidney morphogenesis (Figure
2.7 G,H).

Assessing the Effects of Nuclear and Cytosolic Targeted HDAC4 and HDAC5 Expression
Constructs
In muscle tissue, HDAC4 is CaMK-II responsive due to a specific docking domain and
two CaMK-II phosphorylation sites at sites S467 and S632 (sites S458 and S606 in zebrafish).
Phosphorylation at these sites causes translocation from the nucleus to the cytosol. HDAC5 is
CaMK-II responsive in the presence of HDAC4 through the use of its phosphorylation sites at
S259 and S498 (sites S251 and S480 in zebrafish) (Backs et al, 2008). Previous results show that
CaMK-II affects localization of HDAC4 in pronephric cells as well. In order to determine whether
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phosphorylation at these sites is necessary for correct localization in pronephric cells, four kidney
targeted constructs were generated that localize HDAC4 and HDAC5 either to the nuclear or to
the cytosol. The nuclear targeted constructs were generated by causing a point mutation at the
CaMK-II responsive sites changing the serine to an alanine, thereby inhibiting phosphorylation.
The cytosolic targeting constructs were made by changing the serine to either an aspartic acid or a
Glutamic Acid, which mimics phosphorylation at these sites and should localize it to the cytosol.
Preliminary studies with these constructs analyzed ductal convolution in injected embryos. This
resulted in a loss of convolution in 50% of nuclear targeted HDAC4 injected embryos, while
embryos expressing cytosolic HDAC5 remained unaffected (Figure 2.8) (Figure 2.9).
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Discussion
This study aimed to investigate the link between calcium signaling and epigenetic
regulation by histone deacetylases during kidney morphogenesis. It also provides new insight into
potential therapeutic targets for autosomal dominant polycystic kidney disease (ADPKD) patients.
Calcium is a necessary signaling component for kidney morphogenesis, with Ca 2+ flux during
development occurring in part through the cation channel encoded for by the gene PKD2, a gene
whose mutation is known to cause the development of polycystic kidney disease (Igarishi and
Somlo, 2002) (He et al, 2011). In zebrafish models of ADPKD, loss of calcium signaling through
mutations in pkd2 cause a decrease in the activity of Ca 2+/calmodulin dependent protein kinase 2
(CaMK-II) (Rothschild et al, 2011). Loss of CaMK-II activity causes defects similar to pkd2
morphants including the development of anterior pronephric cysts, loss of cell migration and ductal
convolution in the pronephros, as well as defects in left-right asymmetry, hydrocephaly, and
dorsal-axis curvature (Rothschild et al, 2011). Although CaMK-II is known to be necessary for
kidney morphogenesis, the downstream targets of CaMK-II activity in the pronephros have yet to
be elucidated.
Associations between CaMK-II and Class II HDACs have been reported in cardiac tissue
(Backs et al, 2008). In cardiac tissue, HDAC4 is directly phosphorylated at sites S467 and S632
by CaMK-II inducing the binding of chaperone proteins and sequestration in the cytosol (Backs et
al, 2008). This study is the first to demonstrate that CaMK-II has a similar effect on HDAC4 in
pronephric cells during kidney morphogenesis. Suppression of camk2g1 caused translocation of
HDAC4 into the nucleus thereby preventing transcription of its target genes. Autonomous CaMKII is present in both the anterior and posterior pronephric duct and loss of activity causes specific
defects in those regions (Rothschild et al, 2011). Therefore, it is likely that the sequestration of
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HDAC4 in the cytosol enables transcription of specific target genes for the anterior and posterior
pronephros.
Anterior pronephric defects caused by inhibition of camk2g1 activity include loss of
cellular migration and ductal convolution (Rothschild et al, 2011). CaMK-II has previously been
associated with focal adhesions turnover in cell culture. Suppression of CaMK-II activity caused
an increase in the size of focal adhesion complexes and a decrease in cell motility (Easley et al,
2008). In contrast, constitutively active CaMK-II caused a loss of phospho-tyrosine levels in focal
adhesion kinase (FAK) and paxillin causing a reduction in the size of focal adhesion complexes
and a decrease in cell motility (Easley et al, 2008). As cell motility and convolution defects are
seen in the pronephric ducts of camk2g1 morphants and convolution defects are rescued with
hdac4 inhibition, it is possible that targets of hdac4 include genes that promote focal adhesion
turnover, enabling ductal convolution to take place. However, these results also suggest that
pronephric cell migration and convolution involves several pathways, as convolution was rescued
in camk2g1 morphants with hdac4 suppression but the pronephric cells still were unable to
migration to their normal anterior position.
Posterior defects in camk2g1 morphants include loss of cloacal cilia development and
stability. Inhibition of hdac4 caused elongation of cloacal cilia suggesting that targets of hdac4
promote primary cilia formation in the cloaca. This could occur through transcription of a gene
called missing in metastasis (MIM). This gene has been previously identified as being required in
the basal bodies for cilia maintenance (Bershteyn et al., 2010). This gene is also known to be a
target of MEF2C, which has previously been established to be regulated by HDAC4 (Saarikangas
et al, 2011). This suggest that a possible mechanism could be that sequestration of hdac4 in the
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cytosol by camk2g1 enables meft2c gene transcription in the posterior kidney, which in turn
promotes cilia formation through transcription of mim.
In mouse and zebrafish models, suppression of HDAC through pharmacological inhibition
reduced cyst formation in pkd2 mutant and morphants (Cao et al, 2009) (Xia et al, 2010). Similar
results were produced with the use of the pan-HDAC inhibitor TSA, where treatment was able to
prevent cyst formation in camk2g1 morphants as well as rescue ductal convolution, ciliary length,
and cell migration. Although our results show that both hdac4 and hdac5 play roles during kidney
morphogenesis, our results suggest that TSA acts to rescue kidney development primarily though
inhibition of hdac4.
Previous research has shown that HDAC5 can be responsive to HDAC4 in the presence of
CaMK-II (Backs et al, 2008). However, unlike HDAC4, HDAC5 does not possess a specific
CaMK-II docking site, and it is only responsive through interactions with HDAC4. Loss of hdac5
activity resulted in defects in ductal convolution and cell migration as well as caused the
development of kidney cysts (Backs et al, 2008). In contrast to hdac4, suppression of hdac5 was
not able to rescue ductal convolution or cell migration in camk2g1 morphants. In fact, defects were
exacerbated with branching of the pronephric ducts occurring. This suggest that although both
camk2g1 and hdac5 influence kidney morphogenesis, they work in separate pathways. This was
also supported by camk2g1 inability to affect the localization of hdac5.
Results from this study lead to the following proposed model of action. During normal
development, calcium flux though the cation channel PKD2 enables activation of CaMK-II.
CaMK-II is then able to become autonomous and interact with HDAC4, retaining it the cytosol
allowing for transcription of its target genes. In camk2g1 inhibited embryos, HDAC4 is unable to
be retained in the cytosol, so it translocates to the nucleus, where it inhibits transcription of genes

29

necessary for development (Figure 2.10). Future studies will include the use of kidney targeted
HDAC4 and HDAC5 constructs that should localize to either the nucleus or the cytosol in order
to further validate this model. The inactive HDAC4 and HDAC5 constructs have a mutation
preventing phosphorylation known CaMK-II phosphorylation sites. Based upon our model, this
mutation should cause HDAC4 to localize to the nucleus as it is unable to be phosphorylated by
CaMK-II. The cytosolic targeted HDAC4 contained a phosphomemetic mutation the two known
CaMK-II phosphorylation sites which should cause its retention in the cytosol. Based upon
previous research, it is expected that the same mutations will cause nuclear or cytosolic localization
in the HDAC5 construct as well. However, these two sites are CaMK-II responsive sites. As this
data suggest that CaMK-II and HDAC5 are working in separate pathways to affect kidney
morphogenesis, it is possible that it is phosphorylation at other sites that affect HDAC5 activity
during development.
This study newly identifies HDAC4 as a target of CaMK-II during kidney morphogenesis.
It also provides a potential area of interest for new therapeutic targets for ADPKD. However, this
study also demonstrates that specific pharmacological inhibitors may be necessary when designing
treatments for ADPKD. Although inhibition of hdac4 was able to rescue convolution in camk2g1
morphants, those defects were exacerbated by inhibition of hdac5. Based on these results,
investigators should aim for more specific methods of treatment as these two proteins appear to
have opposing effects on kidney development.
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Figure 2.1 Morphology of class II hdac morphants: Embryos were injected with 2ng of control,
2ng of hdac4, 2ng of hdac5, or 8ng of hdac6 MO. Gross morphology was assessed at 24hpf, 48hpf,
and 72hpf (A-L). Scale bar = 500 µm. HDAC4 morphants showed orofacial defects including
partial cleft (N) compared to control embryos (M) at 72hpf. Scale bar = 100µm. Acetylated histone
H3 levels were assessed at 48hpf in control embryos (O,Q), 2ng hdac4 MO (P), or 2ng hdac5 MO
(R). Scale bar = 5µm. Acetylated α-tubulin was assessed in control (S) and 8ng hdac6 MO (T)
embryos. Scale bar = 500µm. Semiquantitative RT-PCR reaction analyzed the expression of class
II HDACs during development (U-W). Expression was also assessed using whole-mount in situ
hybridization at the one cell stage and 48hpf (X, Y, Z).
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Figure 2.2 Kidney cysts are visible in hdac5 morphants. Dorsal views of 48hpf embryos
injected with 2ng control, 2ng hdac4, 2ng of hdac5, or 8ng of hdac6 MO (A-D). Kidney cysts are
visible in hdac5 morphants (C). Class II HDAC morphants were immunostained for α1
Na+K+ ATPase at 72hpf and imaged at low magnification (E-H) and high magnification (I-L).
Scale bar = 100µm. Hdac5 morphant embryos show of loss of ductal convolution (M) and loss of
anterior migration (N). n=40-70 embryos per experiment. *P < 0.005.
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Figure 2.3. Inhibition of hdac4 and hdac5 cause opposing effects on primary cilia. Lateral
views of primary cilia in the junction of a pronephric duct with the cloaca in 72hpf embryos
immunostained for acetylated tubulin (A-D). Scale bar = 5 μm. Length and number of cloacal cilia
were assessed at 72hpf and compared to controls (E,F). n = 15–30 embryos. *P < 0.005. Cardiac
asymmetry was analyzed by cmlc2 expression at 24 hpf (G–I) and plotted as a percentage of
embryos (J). n = 20–38 embryos. Primary cilia length in the KV at the 12‐somite stage (K–M) is
averaged (N). n = 40–60 cilia. Scale bar = 5 μm. *P < 0.005.
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Figure 2.4. Pharmacological inhibition of class II HDACs mimic morphant phenotype.
Embryos were treated with 0-200nM trichostatin A or 10μM tubastatin A beginning at the cleavage
state. Cloacal cilia were imaged at 72hpf (A,B) and averaged (C). Scale bar = 5μm. n = 15–30
embryos. Cardiac asymmetry was assessed at 30hpf (D). n = 30–40 embryos. Anterior kidney
convolution (E) and kidney ear distance (F) were determined at 72hpf. n = 15–26 embryos.
*P < 0.005.
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Figure 2.5. CaMK-II and HDACs work in the same molecular pathway enabling anterior
kidney morphogenesis. Embryos were injected with camk2g1 MO (1 ng), hdac4 MO
(2 ng), hdac5 MO (2 ng), camk2g1 and hdac MOs together, or the camk2g1 MO followed by bud‐
stage trichostatin A treatment. Embryos were laterally imaged at 72hpf using DIC optics (A–E) or
imaged dorsally using immunofluorescence of α1 Na +/K+ATPase (F–O). Scale bars = 100μm.
Arrowheads in I and N indicate adventitious lumens, and arrows indicate branched ducts.
Convolution was assessed at 72hpf (P) and pronephric migration was assessed by posterior ear‐
anterior kidney distance in μm at 72hpf (Q). n = 30–41 embryos.
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Figure 2.6. CaMK-II and HDACs work in the same molecular pathway leading to cloacal
cilia development and stabilization. Embryos were injected with the camk2g1 MO (CaMKII;
2 ng), hdac
4 MO
(2 ng), hdac5 MO
(2 ng), camk2g1 and hdac MOs
together,
or
the camk2g1 MO followed by bud‐stage trichostatin A treatment. Embryos were imaged at 72 hpf
after immunolabeling with acetylated tubulin (A–E, green). Scale bar = 5 μm. Cilia number and
length were assessed at 72 hpf and compared to control embryos and camk2g1 morphants (F,G).
*P < 0.005 compared to control embryos. **P < 0.005. N = 25–62 cilia.
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Figure 2.7. HDAC4 subcellular localization is altered with inhibition of camk2g1. Embryos
were injected with EGFP‐HDAC5 (30 ng/μl) alone (A,C), EGFP HDAC5 and camk2g1 MO (1 ng)
(B,D), EGFP‐HDAC4 (30 ng/μl) alone (E,G), and EGFP‐HDAC4 and camk2g1 MO (1ng) (F,H).
Embryos were analyzed for subcellular localization in muscle cells (A,B,E,F) and kidney cells
(C,D,G,H) at 24hpf and 48hpf. n = 15–20 embryos. Scale bar = 5μm.
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Figure 2.8. Ductal convolution in nuclear targeted HDAC4 embryos. Anterior convolution was
assessed in embryos injected at the 1-4 cell stage with 30ng of Cherry-HDAC4 S488 A S606 A.
Convolution was observed by immunostaining the kidney specific NaKATPase. Ductal
convolution was varied in HDAC4 S488 A S606 A embryos with half having ductal convolution (A)
and half lacking ductal convolution (B). N=4.
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Figure 2.9: Ductal convolution in cytosolic targeted HDAC5 embryos. Anterior convolution
was assessed in embryos injected at the 1-2 cell stage with 30ng of EGFP-HDAC5 S251 A S480 A.
Convolution was observed by immunostaining the kidney specific NaKATPase. Convolution was
observed in control embryos (A, n=2) as well as in HDAC5 S251 A S480 A embryos (B, n=2)
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Figure 2.10. Model of action. Ca2+ flux through PKD2 activates CaMK‐II to sequester HDAC4
in the cytosol. Sequestration of HDAC4 in the cytosol reduces allows for relaxation of the
chromatin and transcription of HDAC4‐target genes. Loss of PKD2 or CaMK‐II induced the
release of HDAC4 translocate to which then translocated to the nucleus to inhibit target expression.
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Chapter 3: Investigations into the Role of CaMK-II in Kidney Cell Migration

Abstract

The serine/threonine protein kinase CaMK-II is known to play several roles during zebrafish
kidney development. These include ciliary stability, pronephric migration, and pronephric
convolution, although the exact mechanisms of these actions are currently unknown. This study
aims to further understand these pathways by investigating three potential mechanisms for CaMKIIs involvement in kidney development. In this study, camk2g1 morphants had decreased rates of
kidney cell migration when compared to controls, causing a decrease in the distance traveled by
migrating cells. Previous research has shown that loss of CaMK-II activity increases the size of
focal adhesion complexes resulting in decreased migratory capabilities. In addition, alterations in
expression of the extracellular matrix protein collagen is caused by loss of pkd2, a cation channel
necessary for CaMK-II activity. As interactions between migrating cells and the ECM are
necessary for focal adhesion formation and turnover, alterations in collagen expression was
assessed in camk2g1 morphants as a possible cause for the decreased rate of migration.
Suppression of camk2g1 caused increases in col2a1a present in the notochord. Suppression of
collagen secretion using the secretory inhibitor Brefeldin A was able to partially rescue pronephric
convolution in morphants embryos. The decreased rate of migration in camk2g1 morphants could
also be caused by loss of notch signaling. Notch signaling is necessary for cell differentiation in
the zebrafish kidney and loss of notch signaling is associated with a loss of cellular migration in
drosophila. Inhibition of camk2g1 caused alterations in notch signaling proteins in the cloaca
which could be restored with inhibition of HDAC4, indicating that notch signaling proteins may
be downstream of CaMK-II and HDAC4 activity during kidney morphogenesis. This study
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contributes to the understanding of the various roles of CaMK-II during kidney morphogenesis.
Although it is likely that the effects of camk2g1 inhibition seen is this study is the result of several
developmental pathways being affected, it is possible that CaMK-II regulation of the subcellular
localization of HDAC4 directly or indirectly regulates notch signaling pathways, which in turn
affects collagen expression and cellular migration. Further studies will be necessary to understand
the potential connections between these pathways.
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Introduction
Autosomal dominant polycystic kidney disease is one of the most common heritable
disease in the world (Igarishi and Somlo, 2002). It is also a disease that in spite of its prevalence,
little treatment options exists. Treatment for this disease currently consist of lifestyle changes such
as a healthier diet and exercise, and medication to alleviate the symptom from the kidney’s reduced
function, such as medications for blood pressure (Helal, 2015). The lack of treatments for this
disease is due partially to gaps in understanding about disease progression. Mutations in genes
PKD1 and PKD2 are known to be the primary causes of ADPKD, with reduced calcium signaling
occurring due to these mutation (Igarishi and Somlo, 2002).
Research occurring within the past 10 years has identified CaMK-II as a downstream
effector of the cation channel PKD2 (Rothschild et al, 2011). In zebrafish models, inhibition of
camk2g1, the predominant form of CaMK-II present in the kidney, causes a loss of cell migration,
loss of ductal convolution, and destabilization of cloacal cilia. In addition, zebrafish with inhibited
camk2g1 also display dorsal axis curvature and develope anterior kidney cyst, mimicking zebrafish
pkd2 morphants (Rothschild et al, 2011) (Mangos et al., 2010) (Obara et al., 2006) (Schottenfeld
et al., 2007). Histone deacetylase 4 (HDAC4) is also affected by a reduction in camk2g1 activity.
Suppression of CaMK-II causes translocation of HDAC4 from its normal location in the cytosol
to the nucleus, thereby inhibiting its target genes (Rothschild et al, 2018). Co-inhibition of CaMKII and HDAC4 is able to recue ductal convolution in camk2g1 morphants, leading to the model in
which CaMK-II works to retain HDAC4 in the cytosol allowing for transcription of its target genes,
thereby promoting kidney development (Rothschild et al, 2018).
In order to develop effective therapeutic techniques for ADPKD patients, this study aims
to further understand how CaMK-II influences kidney development by investigating its roles in
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cellular migration during morphogenesis. Inhibition of CaMK-II is known to cause a loss of kidney
cell migration, but specifically how suppression of CaMK-II activity affects migration is currently
unknown. One possibility, is that CaMK-II affects the rate of cell migration during development.
During kidney morphogenesis, specified pronephric cells undergo epithelialization at
approximately 18hpf before migrating anteriorly where they undergo ductal convolution in order
to connect with the glomerulus (Drummond and Davidson, 2010). Kidney cells maintain specific
rates of migration at distinct periods of development. Prior to 24hpf, kidney cells migrate slowly,
at a rate of approximately 2µm/hour. Beginning at 28.5hpf and continuing until 3dpf, this rate
increases to 6µm/hour (Vasilyev et al, 2009). This increase in rate corresponds to cell proliferation
in the distal segment of the pronephric kidney and the start of active fluid transport into the
pronephric lumen (Vasilyev et al, 2009). Embryos with downregulated CaMK-II exhibit a
dramatic decrease in anterior migration, as measured by the distance between the back of the ear
and the top of the kidney, at 72hpf (Rothschild, et al, 2011).Therefore, it is possible that inhibition
of CaMK-II is affecting the rate at which specified kidney cells migrate, thereby preventing
connection with the glomerulus and kidney function.
If CaMK-II is affecting the rate at which kidney cells migrate during development, then it
is important to understand specifically what is slowing migrating cells. During development,
kidney cells migrate via collective cell migration. Collective cell migration is reliant upon the
formation of focal adhesion complexes that form when the extracellular matrix proteins interact
with integrin receptors in motile cells (Easley et al, 2008). Alteration in extracellular matrix
components have long been associated with cyst development. Human ADPKD cells exhibit an
overproduction of extracellular matrix components when compared to normal cells (Wilson et al,
1992). These cells also have decreased migratory capabilities due to their increased adhesiveness
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to the extracellular matrix component collagen (Drummond, 2011). Alterations in ECM proteins
have also been seen in animal models of ADPKD. In mouse models, kidney cyst development is
associates with irregular expression of several ECM proteins including collagen and laminin
(Ebihara et al, 1995).
Zebrafish models for ADPKD exhibit similar alterations in ECM components. Body
curvature is a consistent phenotype seen in morphants for both pkd2 and camk2g1 (Schottenfeld
et al, 2007) (Rothschild et al, 2011). This body curvature is associated with an increased amount
of type II collagen present in the notochord sheath (Mangos et al, 2010). Zebrafish pkd2 morphants
also have an increased expression of col2a1, col9a2, and col27al in the notochord due to alterations
in post translational modification (Mangos et al, 2010) (Le Corre et al, 2014). This increase is
associated with an increase in COPII secretory proteins, proteins are responsible for collagen
trafficking from the ER to the Golgi (Le Corre et al, 2014). Increases in expression of these proteins
led to the idea that alterations in ADPKD ECM components could be associated with alterations
in secretion of ECM proteins from the notochord to the kidney (Le Corre et al, 2014). In fact,
zebrafish pkd2 morphants treated with Brefeldin A, a pan COPII dependent secretory inhibitor,
showed a significant reduction in cyst formation as well as a rescue of dorsal axis structure (Le
Corre et al, 2014). As camk2g1 morphants exhibit the same body curvature as pkd2 morphants, it
is possible that loss of CaMK-II activity causes an increase in collagen expression which increases
kidney cells adhesiveness to the ECM during morphogenesis, thereby slowing and/or preventing
migration (Rothschild et al, 2011). This would also correspond with previous studies, showing that
pharmacological inhibition of CaMK-II causes a decrease in cell motility and an increase in the
size of focal adhesion complexes (Easley et al, 2008).
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Another pathway that may play a role in cellular migration during kidney development is
the notch signaling pathway. Notch signaling acts through receptor-ligand interactions which
causes the cleavage of the notch intracellular domain (NICD) (Bray, 2016). The NICD then
translocates to the nucleus where, through interactions with other regulatory proteins, it mediates
transcription of its target genes (Bray, 2016). This pathway is involved in a number of biological
processes including cell fate, stem cell regulation, and heart morphogenesis (Fuss et al, 2004)
(Bray, 2016). It also has roles in disease pathologies such as certain cancers and polycystic kidney
disease (Bray, 2016) (Idowu et al, 2018).
Notch signaling has previously established roles in kidney development through cell fate
determination of transporting epithelia and multi-ciliated cells in the pronephric ducts (Liu et al,
2007). In addition, regulation of notch signaling has been previously linked to both CaMK-II and
HDACs. Pharmacological inhibition of CaMK-II caused a loss of Notch-1 signaling in cell culture
(Mamaeva et al, 2008) while treatment with TSA, a pan-HDAC inhibitor, reduced Notch-3 protein
levels in human leukemia cell lines (Pinazza et al, 2018). Inhibited Notch signaling has also been
linked to reduced cell migration in Drosophila (Fuss et al, 2004). Therefore, it is possible that
notch signaling components may be the next step in the previously establish pathway of PKD2
activated CaMK-II regulating HDAC4 during kidney development (Rothschild et al, 2018). It is
hypothesized that inhibition of CaMK-II will cause a loss of notch signaling, possibly though the
alterations of the subcellular localization of HDAC4.
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Methods

Zebrafish Strains and Care
Zebrafish embryos were obtained though natural matings and raised at 28.5°C (Kimmel et al,
1995). Zebrafish strains used were Wild-type (AB and WIK), Tg(Tp1:GFP), and
Tg(NakATPase:GFP)

Morpholino Injections
Translation-blocking antisense morpholinos were designed to target zebrafish camk2g1 (1ng),
hdac4 (2ng), and hdac5 (2ng), purchased from Gene Tools along with a control mismatch
morpholino (2ng). All morpholinos were used as previously described with an injection volume
of 1nl (Francescatto et al., 2010) (Rothschild et al., 2011) (Rothschild et al., 2013). The
morpholinos for hdac4 and hdac5 were designed to target the following the regions around the
translation start site: hdac4: CGCCACACTCACATCAACCATCAGC; nucleotides ‐11 to + 14),
hdac5: GATCTTCCCTGCCTGAAGTTCTCCA; nucleotides ‐38 to ‐14).

Whole Mount In Situ Hybridization
Digoxigenin‐labeled antisense riboprobes were synthesized as previously described using T3 or
T7 RNA polymerase (Rothschild et al., 2007). Embryos used for whole‐mount in situ
hybridization

(WISH)

were

developed

using

alkaline

phosphatase–conjugated

anti‐

digoxigenin. The col9a2 probe was designed using the following primers: Sense 5’ AGGTGCT
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ACCGGAATGATTG 3’, Antisense 5’ GGATCCATTAACCCTCACTAACGGGAGGTCCAG
GTCGTCCTG 3’. The col27a1a probe was designed using the following primers: Sense 5’
AACCACAAGGGCAAGAATTG 3’, Antisense 5’ CAGGTGTTGTTGTGGTTGGA 3’. DeltaC
and Col2a1a were provided by Wilson Clements, Ph.D. at St. Jude Children’s Research Hospital.
Probes for Hdac4 and hdac5 were designed to correspond to sequences amplified using the primer
sets previously mentioned.

Drug Treatment
Control zebrafish embryos and camk2g1 morphants were incubated in 5 μM Brefeldin A (BFA) in
1.9ml of E3 water with 1.0µl PTU starting at 24hpf continuing until fixing at 48hpf.

Fluorescent Localization
Embryos were fixed in 4% paraformaldeype or Dent’s fixative as previously described (Rothschild
et al., 2011). Embryos were then incubated with mouse anti‐α 1 Na+/K+‐ATPase (Developmental
Studies Hybridoma Bank, University of Iowa [α6F] at a 1:10 dilution). After overnight incubation
in primary antibody, embryos were incubated with the secondary antibody goat anti‐rabbit
Alexa568 (Invitrogen at 2.5 μg/ml) and imaged using confocal microscopy. Embryos were imaged
either on a Nikon E600 compound microscope using a 10X dry, 20X dry, or 40X dry objective, or
on Nikon AZ‐100 Macro Zoom fluorescent stereo microscope.
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Video Microscopy
Embryos were imaged by confocal microscopy (Nikon C2 Plus two-laser) on a Nikon Eclipse Ni
compound microscope using a 20X dry objective or on a Nikon AZ-100 macro zoom fluorescent
stereo microscope using Elements AR 4.50 software. Embryos used for live imaging for kidney
migration rates were anesthetized and mounted on a slide using 1.0% low melting agarose (product
name). Embryos used for tp1 expression images were anesthetized and mounted directly only a
slide with E3 water.

CaMK-II Expression Constructs
Kidney targeted WT and K43 A CaMK-II expression constructs using the Na+/K+-ATPase promoter
(Liu et al., 2007) were generated using Gateway technology as previously described (Invitrogen)
(Francescatto et al., 2010).

DeltaC Rescue
Hdac4 MO (2ng) and camk2g1 MO (1ng) were co-injected into zebrafish embryos at the one cell
stage. DeltaC expression was assessed at 24hpf using WISH as described above.

Statistical Analysis
Statistical significance was set at P<0.05 using the two-tailed t-test

49

Results

Pronephric cell migration is unaffected in DN CaMK-II injected embryos
In order to assess whether inhibition of CaMK-II affects the rate of migration of kidney
cells, zebrafish embryos were injected with either a kidney targeted cherry-tagged WT CaMK-II
or a kidney targeted GFP-tagged dominant negative (DN) CaMK-II which lacks
phosphotransferase ability. This resulted in embryos with mosaic expression, where florescent
kidney cells expressed the injected construct and non-fluorescent cells remained unaffected.
Migration rates were first assessed in WT CaMK-II embryos. Fluorescent cells present in the
medial portion of the pronephros moved a total distance of 28.3µm between 50hpf to 55hpf or
5.6µm/hr (Figure 3.1). This is consistent with previous finding stating that pronephric cells migrate
faster than their normal 2µm/hr during the time period between 28.5hpf and 3dpf (Vasilyev et al,
2009). WT CaMK-II positive cells in the distal regions of the kidney migrated slower at 2.2µm/hr
(data not shown). This is also consistent with previously published data as the distal portion of the
pronephros is necessary for cell proliferation and not migration (Vasilyev et al, 2009). This rate of
migration was unaffected by the injection of DN CaMK-II. Kidney cells expressing DN CaMK-II
had a migrated a total of 22µm from 48hpf to 53hpf, retaining an increased rate of migration of
4.4µm/hr (Figure 3.2) (Supplemental Video 3.1). Embryos expressing DN CaMK-II also exhibited
no defects in cell proliferation, as cell division was visible in the distal portion of the pronephros
(Supplemental Video 3.2).
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Pronephric cell migration is decreased in camk2g1 morphants
In order to evaluate the rate of migration of kidney cells in camk2g1 morphants,
NakATPase:EGFP embryos were injected with 1ng of camk2g1 morpholino. The rate of migration
in uninjected embryos was found to be consistent with previous published data (Vasilyev et al,
2009). Pronephric cells migrated 27.22µm between 49hpf and 50hpf or 5.44µm/hr (Figure 3.3)
(Supplemental Video 3.3). Camk2g1 morphants do not reach this increased rate of migration.
Pronephric cells in camk2g1 morphants migrated a total of 8.75µm between 54hpf and 59hpf or
1.75µm/hr (Figure 3.4) (Supplemental Video 3.4). This migration rate of camk2g1 morphants is
lower than both uninjected embryos and embryos injected with WT CaMK-II. Interestingly, it’s
also reduced when compared to embryos injected with DN CaMK-II (Figure 3.5). This could be
due to the camk2g1 morpholino being more evenly distributed among pronephric cells compared
to the kidney targeted DN CaMK-II embryos.

Col2a1a expression is increased in camk2g1 morphants
Dorsal axis curvature is a common phenotype in zebrafish pkd2 morphants as well as
camk2g1 morphants (Schottenfeld et al, 2007) (Rothschild et al, 2011). In pkd2 morphants, this
body curvature was suggested to be due to an increased amount of col2a1a, col9a2, and col27a1a
expression (Mangos et al, 2010). In order to determine if this is also true for camk2g1 morphants,
whole mount in situ hybridization was used to assess col2a1a expression at 48hpf in both
uninjected embryos and camk2g1 morphants. Similar to pkd2 morphants, col2a1a expression was
dramatically increased in the notochord at 48hpf (Figure 3.6). Col9a2 expression was also found
to be upregulated in pkd2 morphants. However, it was unchanged in camk2g1 morphants at 48hpf
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(Figure 3.6). Preliminary data suggest that there may be an increased in col27a1a expression in
camk2g1 morphants, similar to what was seen in pkd2 morphants (data not shown). However, this
requires further examination.

Treatment with secretory inhibitor Brefeldin A partially rescue ductal convolution in
camk2g1 morphants
Increases in col2a1a levels in pkd2 morphants was found to be related to an increase in
complex II Sec proteins pointing to an increase in collagen secretion (Le Corre et al, 2014).
Treatment with Brefeldin A (BFA) a COPII secretory inhibitor, not only prevented body curvature
in pkd2 morphants, but also reduced cyst formation as well (Le Corre et al, 2014). As camk2g1
morphants also exhibit increases in col2a1a expression, it was of interested to determine whether
treatment with BFA could rescue kidney defects seen in camk2g1 morphants, namely the loss of
ductal convolution. Treatment with 5µM of BFA did not affect development of uninjected wild
type embryos but was able to restore ductal convolution in camk2g1 morphants (Figure 3.7)
(Figure 3.8). Convolution was seen in just under 50% of embryos treated with 5µm of BFA,
compared to only approximately 20% in untreated camk2g1 morphants (Figure 3.8).

Notch Signaling is decreased in camk2g1 morphants
The notch signaling pathway is known to be necessary for kidney morphogenesis (Liu et
al, 2007). In addition, it has also been linked to both CaMK-II and HDACs in cell culture
(Mamaeva et al, 2008) (Pinazza et al, 2018). In order to determine if inhibition of CaMK-II is
altering notch signaling during development, the camk2g1 morpholino was injected into transgenic
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embryos expressing GFP labeled tp1, a notch response element (Parsons et al, 2009). Tp1
expression can be seen in the zebrafish cloaca at 24hpf as well as 48hpf (Figure 3.9) However, this
expression is reduced or lost in camk2g1 morphants (Figure 3.9). Uninjected embryos had an
average of 3 tp1 positive cells in the cloaca at 24hpf and 5 tp1 positive cells at 48hpf. This number
was significantly decreased in camk2g1, where most embryos have no tp1 expression at 24hpf and
only 2-3 positive cells at 48hpf (Figure 3.10, p<.05).

DeltaC expression is increased in the cloaca in camk2g1 morphants and hdac5 morphants
In order to further investigate the connections between notch signaling and the CaMK-IIHDAC4 pathways during kidney morphogenesis, expression of the notch ligand deltaC was
assessed using WISH in embryos injected with the camk2g1 MO, hdac4 MO, or the hdac5 MO.
DeltaC expression was unchanged in HDAC4 morphants, but was increased in the cloaca in hdac5
morphants (Figure 3.11). Inhibition of camk2g1 also caused an increase in deltaC expression in
the cloaca at 24hpf (Figure 3.11). This increase in expression was not seen at 48hpf (Figure 3.12).
The increase in deltaC expression is consistent with previous findings on the regulation of Delta
ligands by CaMK-II in the inner ear, where camk2g1 morphants shows increased levels of deltaA
and deltaD expression (Rothschild et al, 2013). The increase in deltaC expression seen in camk2g1
morphants could indicate a feedback loop in which a loss of response from the receptor could
signal for increased ligand production in an effort to complete the signaling pathway.
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Suppression of HDAC4 in camk2g1 morphants rescues deltaC expression
Pronephric duct convolution is lost when camk2g1 activity is inhibited and is able to be
rescued with co-suppression of hdac4. In order to determine whether hdac4 is able to have the
same effect on the notch signaling pathway, deltaC expression was assessed in embryos injected
with both the hdac4 MO and camkg1 MO. DeltaC expression is increased in the cloaca at 24hpf
in camk2g1 morphants. (Figure 3.11).

This increased expression is prevented in camk2g1

morphants with suppressed hdac4 (Figure 3.13). This suggest a possible role for CaMK-II-HDAC4
pathway in the regulation of notch signaling during kidney morphogenesis, This could occur
through direct regulation of deltaC expression or through regulation of the Notch receptors, as
CaMK-II has previously been shown to regulate Notch signaling in cell culture (Ann et al., 2012)
(Mamaeva et al., 2009).
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Discussion

This study aimed to investigate the role of CaMK-II in the previously reported migratory
defects associated with zebrafish models of ADPKD. Inhibition of camk2g1 in zebrafish embryos
causes a loss of cell migration in kidney cells (Rothschild et al, 2011). This study has determined
that this could be due to an inability of migrating cells to reach an increased rate of migration
normally seen between 28.5hpf and 3dpf (Vasilyev et al, 2009).
Formation of the zebrafish pronephros is reliant upon the anterior migration of pronephric
cells to a specific location where they can convolute inward and connect with the glomerulus
(Vasilyev et al, 2009). This migration occurs collectively, with cells maintaining apical cell-cell
junctions. Cell migration is initiated at the start of active fluid transport to the pronephros, after
which migrating cells form transient focal adhesion complexes with the basement membrane,
while extending lamellipodia in the direction of movement (Vasilyev et al, 2009).
The formation and subsequent disassembly of focal adhesion complexes is an integral step
in cell migration as cells use them as anchor points to pull themselves along during migration.
Focal adhesion complexes are multi-protein structures that form when integrins in the migrating
cell interact with the ECM, inducing autophosphorylation of focal adhesion kinase (FAK), which
in turn recruits src, paxillin, and a number of other focal adhesion proteins (Easley et al, 2008).
Disassembly of focal adhesion complexes is associated with transient elevations in Ca2+ and
CaMK-II has been shown to have a role in focal adhesion turnover by inducing the
dephosphorylation of FAK and paxillin (Easley et al, 2008).
In cell culture, alterations in CaMK-II activity inhibited cell motility and caused alterations
in FAK and paxillin phosphorylation in focal adhesion complexes (Easley et al, 2008).
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Pharmacological inhibiton of CaMK-II over stabilized paxillin and caused an increase in the size
of focal adhesion complexes (Easley et al, 2008). Conversely, constitutively active CaMK-II
caused a decrease in FAK and paxillin phosphorylation, resulting in a decrease in cell motility as
cells were less adhesive to the ECM (Easley et al, 2008).
In this study, camk2g1 morphants exhibited a slower rate of migration during the time
period in which increased migration rate in essential in order to form a functional kidney. As
previous research has indicated that loss of CaMK-II causes over stabilization of focal adhesion
complex, it is possible that there is a loss of focal adhesion turnover in camk2g1 morphants,
inhibiting migration. Future research should focus on assessing expression of focal adhesion
proteins during kidney morphogenesis, specifically FAK and paxillin as these are known to be
responsive to alteration in CaMK-II activity.
It is of note that this decrease in migration was only seen in embryos injected with the
camk2g1 morpholino and not in embryos injected with the DN form of CaMK-II, K43 A. This could
be due to the more even distribution of the morpholino among kidney cells. In the course of this
study, injection of the DN CaMK-II construct produced fluorescence in approximately 10 or less
kidney cells per embryos and often these were distributed along the length of the pronephros,
occurring primarily in the medial and distal portions. Previously, expression of DN CaMK-II was
shown to cause significant decreases in cell migration as well as cause abnormal branching in the
pronephros. However, in that instance, positive cell were clustered at the anterior end as opposed
to being more evenly distributed as seen in this study (Rothschild et al, 2011). As kidney cells
migrate collectively, with each cell maintaining cell junctions while following the path of the cell
on the leading end, it is likely that the disruption in migration was caused by the leading edge cells
expressing DN CaMK-II (Rothschild et al, 2011). In the current study, the leading edge cells
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remained wild type, while the cells expressing DN CaMK-II were medial and distal. Therefore, it
is likely that because the cells migrate collectively, the wild type cells were able to compensate for
any defects in the GFP positive cells in the middle, preventing any alterations in migration rate.
In addition to alterations in focal adhesion complexes, this study points to another potential
pathway where an increase in col2a1a in camk2g1 morphants may be a cause of reduced migration.
Collective cell migration is reliant upon formation and disassembly of focal adhesion between
migrating cells and the extracellular matrix (ECM) (Vasilyev et al, 2009). As increases in collagen
density have been reported to slow or prevent migration in cell culture, increase in collagen
expression may be preventing migration during kidney development (Kuzcek et al, 2019). This is
further supported by a reduction in kidney defects with treatment of Brefeldin A, a secretory
inhibitor previously shown to reduce secretion of col2a1a in pkd2 morphants (Vasilyev et al,
2009). This potential pathway requires further examination, with future studies focusing on
expression of kidney specific collagen protein, such as col27a1a, and other secretory proteins in
camk2g1 morphants.
This study has also identified CaMK-II regulation of notch signaling as a potential pathway
of interest. This is supported by a decrease in tp1 expression in the cloaca at 24hpf and 48hpf.
Inhibition of camk2g1 also caused an increase in deltaC expression in the cloaca, suggesting a
feedback loop where increased expression of the notch ligand is attempting to compensate for the
loss of response from the receptor (Ma and Jiang, 2007). The increase in deltaC was able to be
rescued by suppression of hdac4, mimicking previous research where inhibition of hdac4 was able
to partially rescue kidney defects in camk2g1 morphants.
It is possible that camk2g1 regulation of notch signaling may play a role in cellular
migration. Alterations in notch signaling components were seen in the cloaca, which is the sight
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at which inhibition of camk2g1 was shown to cause a loss of cloacal cilia, potentially inhibiting
the fluid flow necessary for migration (Rothschild et al, 2011). In addition, murine cell culture
transfected with a constitutively active form of the notch 1 receptor had decreased expression of
type II collagen, suggesting that the notch signaling pathway may play a role in collagen regulation
(Blaise et al, 2009). Therefore a potential pathway may be that notch activity, regulated by the
previously established CaMK-II-HDAC4 pathway, is providing a similar function during kidney
morphogenesis, and its inhibition is resulting in increased collagen expression and reduced
migration. However, this pathway is speculative, and requires further study for validation.
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Figure 3.1. Migration distance in WT CaMK-II embryo. Embryos were injected with 100ng of
the WT CaMK-II construct Cherry:CaMK-II. Embryos were imaged every 15 minutes between
50hpf and 55hpf. The imaged cell moved a total of 28.31µm over the five hour time period or
5.66µm/hour
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Figure 3.2. Migration distance in DN CaMK-II embryo. Embryos were injected with 100ng of
the DN CaMK-II construct GFP-K43 A. Embryos were imaged every 15 minutes between 48hpf
and 53hpf. The imaged cell moved a total of 22µm over the five hour time period or 4.4µm/hour.
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Figure 3.3. Migration distance in NakATPase:EGFP embryos. NakATPase:EGFP embryos
were imaged every 15 minutes between 49hpf and 59hpf. Imaged cells moved an average of
27.22µm over the five hour time period or 5.44 µm/hour.
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Figure 3.4. Migration distance in camk2g1 morphants. NakATPase:EGFP embryos were
injected with 1ng of camk2g1 morpholino. Embryos were imaged every 15 minutes between 54hpf
and 59hpf. The imaged cell moved a total of 8.75µm over the five hour time period or
1.75µm/hour.
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Figure 3.5. Average migration distance WT and CaMK-II inhibited embryos. Migration
rates were analyzed in embryos injected with 100ng of Cherry:CaMK-II, 100ng of DN CaMK-II
construct, or 1ng of camk2g1 MO, as well as uninjected NakATPase:EGFP embryos. There was
no difference in migration rates between WT CaMK-II (number of positive cells = 3), DN
CaMK-II (number of positive cells = 6), or NakATPase:EGFP embryos (number of positive cells
= 3). However, preliminary data suggest there may be a decrease in cell migration rates in
camk2g1 morphants (number of positive cells = 2).
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Figure 3.6. Col2a1a expression is increased at 48hpf in camk2g1 morphants. Col2a1a and
Col9a2 expression was assessed at 48hpf using anti-sense RNA probes and WISH. Col2a1a
expression is increased in the notochord at 48hpf in camk2g1 morphants (n=9) when compared
to control (n=8). Col9a2 is unchanged in camk2g1 morphants (n=7) when compared to control
(n=6).
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Figure 3.7: Ductal convolution in camk2g1 morphants treated with secretory inhibitor
Brefeldin A (BFA). Anterior convolution was assessed at 48hpf in camk2g1 morphants treated
with secretory inhibitory, Brefeldin A. Convolution was observed by immunostaining the kidney
specific NaKATPase in untreated controls (A, D), untreated camk2g1 morphants (B, E), and
camk2g1 morphants treated with 5µM of Brefeldin A (C, F).

65

Figure 3.8. Ductal convolution in camk2g1 morphants treated with secretory inhibitor
Brefeldin A (BFA). Anterior convolution was assessed at 48hpf in controls (n=19), controls
treated with 5µM BFA (n=11), camk2g1 morphants (n=19), and camk2g1 morphants treated with
5µM of BFA (n=20).
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Figure 3.9. Tp1 expression in control embryos and camk2g1 morphants. The number of GFP
positive cells in the cloaca was assessed in uninjected Tp1:GFP embryos and in Tp1:GFP
embryos injected with 1ng of camk2g1 morpholino at 48hpf. Camk2g1 morphants have a loss of
tp1 expression at 48hpf.
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Figure 3.10. Number of tp1 positive cells in the cloaca in camk2g1 morphants. The number of
GFP positive cells in the cloaca was assessed in uninjected Tp1:GFP embryos and in Tp1:GFP
embryos injected with 1ng of camk2g1 morpholino. Embryos were assessed at 24hpf (A, control
n=25, camk2g1 MO n=25) and again at 48hpf (B, control n=12, camk2g1 MO n=15).
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Figure 3.11. Inhibition of camk2g1 and hdac5 causing an increase in deltaC expression in the
cloaca at 24hpf. Embryos were injected with 1ng of camk2g1 MO, 2ng of hdac4 MO, or 2ng
hdac5 MO. DeltaC expression was assessed using an anti-sense RNA probe and WISH at 24hpf.
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Figure 3.12. DeltaC expression is unchanged at 48hpf. Embryos were injected with 1ng of
camk2g1 MO at the 1-4 cell stage. DeltaC expression was visualized at 48hpf using an anit-sense
RNA probe and WISH. DeltaC expression was unchanged in camk2g1 morphants (n=16) at 48hpf
when compared to controls (n=20)
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Figure 3.13. DeltaC expression is restored to wildtype level in camk2g1 MO with co-inhibition
of hdac4. Embryos were co-injected with 1ng of camk2g1 MO and 2ng hdac4 MO. DeltaC
expression was assessed at 24hpf using WISH.
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Supplemental Video 3.1. Migration Rate of Kidney Cells in a DN CaMK-II Embryo. Live
imaging of a DN CaMK-II injected embryo taken between 48hpf and 53hpf showing pronephric
cells migrating at a rate of 4.40µm/hr
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Supplemental Video 3.2. Cell Division in a DN CaMK-II Embryo. Live imaging of a DN
CaMK-II injected embryo showing cell division in the distal portion of the pronephros.
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Supplemental Video 3.3. Migration Rate of Kidney Cells in a NaKATPase:EGFP Embryo.
Live imaging of a NaKATPase:EGFP embryo taken between 50hpf and 55hpf showing pronephric
cells migrating at a rate of 5.44µm/hr.
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Supplemental Video 3.4. Migration Rate of Kidney Cells in camk2g1 Morphant Embryo.
Live imaging of a camk2g1 morphant embryo taken between 54hpf and 59hpf showing pronephric
cells migrating at a rate of 1.75µm/hr.
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Chapter 4: Genetic compensation in camk2g1 mutants

Abstract
CaMK-II is a Ca2+/calmodulin depending protein kinase encoded by 4 genes (α, β, γ, δ) in
humans, and 7 genes (α, β1, β2, γ1, γ2, δ1, δ2) in zebrafish. Since being first described in the
1970s, CaMK-II has been found in virtually every tissue type and is involved in a variety of cellular
processes including long term potentiation, ion channel regulation, and organogenesis. In zebrafish
embryos with inhibited camk2g1, a variety of developmental defects can be seen including defects
in kidney morphogenesis, the development of pronephric kidney cysts, left-right asymmetry
defects, hydrocephaly, ciliary instability, and aural defects. In an effort to further understand the
roles of camk2g1 during development, a homozygous mutant was generated in zebrafish using
TALEN technology. However, the mutant exhibited none of the phenotypic defects seen in
zebrafish camk2g1 morphants. qPCR analysis of CaMK-II expression in camk2g1 mutant embryos
showed a 3.5 fold increase in camk2g2, its paralog. In addition, several of the other CaMK-II genes
showed a decrease in expression up to 40%, suggesting genetic cross-talk during development.
Generation of G0 camk2g1 mutants using CRISPR/Cas9 exhibited nearly all of the defects seen in
camk2g1 morphants, including kidney defects, cyst development, and ciliary defects. These results
validate the camk2g1 morphant phenotype seen in current and previous studies, and indicate that
genetic compensation does not occur in morphants or G0 mutants, but is developed over time in
stable mutant lines.

This study demonstrates the ability of CaMK-II genes to genetically

compensate for the loss of their paralog and validates the use of knockdown methods such as
morpholinos for future developmental studies.
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Introduction

TALEN and CRISPR/Cas9 Genome Editing
Transcription activator-like effectors (TALEs) are proteins secreted by bacteria that
contain a DNA binding domain enabling them to effect gene transcription in vivo (Nemudryi et
al, 2014). The DNA binding domain of TALEs proteins is formed by monomers made from 34
amino acids with a variable region at positions 12 and 13 (Moscue and Bogdanove, 2009). These
positions follow a specific code enabling targeting to one of the four nucleotides based upon which
two amino acids are present in the variable region. The amino acid in position 12 is necessary for
stabilization and the amino acid in position 13 directly interacts with the targeted nucleotide
(Moscue and Bogdanove, 2009)
. Once this system was understood, an artificial DNA binding domain was created and
placed in a construct with the catalytic domain of FokI, a restriction endonuclease, yielding the
transcription activator-like effector nucleases (TALEN) genome editing method (Nemundryi et al,
2014). This method allows for the use of TALEs monomers designed to target specific regions of
DNA. TALENs are used in pares and are designed to sit on opposite strands of the targeted
sequence (Nemudryi et al, 2014). The FokI domains on the C-terminus end of the TALENs
dimerize with their counterpart on the opposite strand, causing a double stranding break. This
break is then repaired by nonhomologus end joining (NHEJ) an error prone process that often
causes insertions or deletions disrupting the function of the target gene (Lieber, 2010) (Nemudryi
et al, 2014).
Another reliable, commonly used method of genome editing is the CRISPR/Cas9 system.
This method is also derived from bacteria (Nemudryi et al, 2014). However, in contrast to the
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TALEN system, CRISPR/Cas9 relies upon a complex consisting of non-coding RNA and the Cas9
endonuclease. In bacterial cells, a small sequence of invading DNA is inserted into the CRISPR
locus (Nemundryi et al, 2014). This sequences is complementary to the sequence on the foreign
DNA which is located near a specific region known as the PAM (protospacer adjacent motif)
sequence necessary for the targeting of the CRISPR/Cas9 complex (Mojica et al, 2009). After
insertion of the fragment of foreign DNA into the CRISPR locus, it is transcribed, allowing for
targeting of the CRISPR/Cas9 complex to the invading DNA, enabling its degradation (Nemudryi
et al, 2014).
The use of CRISPR/Cas9 in research settings has become a common and reliable method
of genome editing. In mice and zebrafish, the typical method used is to create a single guide RNA
which consist of a designed crRNA targeting the area of interest in the genome and the tracrRNA
which enables the activity of the CRISPR/Cas9 complex. This is microinjected along with either
Cas9 protein or mRNA (Chang et al, 2013) (Wang et al, 2013). Similar to the TALEN system,
once the CRISPR/Cas9 complex binds to its target site, a double stranded break occurs. This break
in then repaired by the error prone NHEJ, leading to inhibition of activity of the target gene
(Nemudryi et al, 2014).
Although the CRISPR/Cas9 system has proven to be a reliable method for gene editing,
some genes have proven resistant to targeted mutations (Gagnon et al, 2014). In order for the
CRISPR/Cas9 system to be effective, a double stranded break must generate a repair that causes a
frameshift mutation and/or a premature stop codon (Nemudryi et al, 2014). In 2014, researchers
attempted to use CRISPR/Cas9 to generate a zebrafish camk2g1 mutant. Microinjection of sgRNA
and Cas9 mRNA was able to successfully generate alteration in the camk2g1 gene in 8 injected
zebrafish embryos. However, none of these insertion/deletions generated a frameshift, leaving a
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fully function protein, suggesting biological repair mechanisms designed to reduce allele diversity
(Gagnon et al, 2014).

Genetic Compensation
The use of genome editing methods like TALEN and CRISPR/Cas9 have become the
standard in reverse genomic studies. However, research has shown discrepancies between the
phenotypes of stable mutants and morphants for particular genes. In fact, a study comparing the
phenotypes of mutants and morphants for 24 specific genes found that only 5 of the compared
genes shared a similar phenotype (Kok et al, 2015). This was further demonstrated through their
own study where 10 of the developed and validated zebrafish mutant lines showed none of the
developmental defects previously published in morphants for the same genes. This led researchers
to the conclusion that many morphant phenotypes are due to off target effects of the morpholino
and are not reliable descriptions of gene function (Kok et al, 2015).
The discrepancy between mutant and morphants phenotypes have been described in a
variety of model organism including zebrafish, mice, and human cell lines (Kok et al, 2015)
(Daude et al, 2012) (Karakas et al, 2007). Although this was originally thought to be due to off
target effects of knockdown mechanisms, recent studies have indicated that genetic compensation
in mutant models may be preventing any developmental defects to due genetic loss (El-Brolosy
and Stainier, 2017). A comparison between a zebrafish mutant and morphant for egf17, an
extracellular matrix gene, showed opposing phenotypes, with egf17 mutants developing normally
and egf17 morphants having severe vascular defects. Addition analysis found that other
extracellular matrix genes were upregulated in egf17 mutants, not in morphants indicating
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compensation by these genes (Rossi et al, 2015). Other studies have produced similar results,
where zebrafish mutants for epoa, a red blood cell regulator, have increased levels of epob
expression, preventing developmental defects (She et al, 2019).
Genetic compensation has been well reported in a variety of studies using a number of
model organisms. However, the exact mechanisms of genetic compensation are currently
unknown. Based upon previously reported studies, several possible explanations exists for the
induction of genetic compensation in mutant models. One thought is that DNA damage causes
epigenetic changes that induce genetic compensation (El-Brolosy and Stainier, 2017). When DNA
is damaged in some way, chromatin remodelers and histone-modifying enzymes act to decondense and reorganize chromatin (El-Brolosy and Stainier, 2017). It has been proposed that
when a mutation occurs, these same mechanism may de-condense chromatin around compensating
genes inducing their upregulation. This idea has been supported by studies in both Drosophila and
C elegans (Stukenholz et al, 1999) (Raj et al, 2010).
Another proposed method for genetic compensation is that compensation is induced by the
presence of mutant mRNA (El-Brolosy and Stainier, 2017). The presence of mutant mRNA
induces the nonsense mediated decay (NMD) pathway (Schuermann, et al, 2015). In zebrafish,
two different mutations were made in the same exon for the gene mt2 which caused two different
levels of NMD activation. The mutant with the higher level on NMD had lesser phenotypic defects
that the mutant with lower levels of NMD response (Schuermann et al, 2015). Several potential
pathways have been proposed for how the presence of mutant mRNA can induce genetic
compensation. One potential pathway is that mutant mRNA acts to bring transcription factors and
chromatin remodelers to the site of compensation genes (El-Broslosy and Stainier, 2017). It has
also been proposed that mutant mRNA could also act through RNA binding proteins (RBPs). RBPs
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act to stabilize mRNA and if the mutant mRNA is unable to bind to the RBPs then they would
become available to stabilize the compensating genes (El Broslosy and Stainier, 2017).
In this study, a zebrafish mutant for the gene camk2g1 was analyzed for the presence of
genetic compensation. Previous research has shown that inhibition of camk2g1 using morpholinos
and dominant negative constructs yielded embryos with severe phenotypic defects including
hydrocephaly, left-right asymmetry defects, kidney defects, and body curvature (Francescatto et
al, 2010) (Rothschild et al, 2011) (Rothschild et al, 2018). The camk2g1 mutant possesses none of
these defects and develops normally. This study aims to validate previously published works on
camk2g1 using knockdown mechanisms while also investigating genetic compensation by other
CaMK-II family members in camk2g1 mutants.
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Methods

Zebrafish strains and care
Wild type (AB and WIK) fish embryos were obtained through natural matings and raised at 28.5°C
as previously described (Kimmel et al., 1995).

Generation of camk2g1 mutant zebrafish and sequence analysis
Camk2g1 mutants were generated and provided by the Thisse lab using the following protocol.
The TALEN to target camk2g1 was designed using TAL Effector Nucleotide Targeter 2.0
(https://tale-nt.cac.cornell.edu/node/add/talen-old), assembled by using the Golden Gate TALEN
and TAL Effector Kit 2.0 (Cermak et al., 2011) and cloned into the pCS2+TAL3DD or
pCS2+TAL3RR (Dahlem et al., 2012). The sequence in the exon 2: TTGCAGGGGTGCCTTCT
CcgtggtgcggagatgtgTGAAAAAATCCACTGGCCA has been targeted using the TALEN
modules= NG NN HD NI NN NN NN NN NG NN HD HD NG NG HD NG HD and NN NN HD
HD NI NN NG NN NN NI NG NG NG NG NG NG HD NI. Synthesized capped mRNAs were
injected into eggs of the AB/Tu strain. Characterization of mutant alleles in F1 adults was assessed
by performing an endonuclease assay using AciI that cuts at GCGG (underlined in the sequence
above) in the linker sequence. The primers used to amplify the DNA fragment around the target
site

were

5’-

TGCATGCGCTATAAGGTGCATTGT-3’

and

5’-GCAACCACACAG

ACACCCTCG-3’. PCR amplification of genomic DNA with these primers (Meeker et al., 2007)
results in production of a 329 bp fragment that is cut into fragments of 88 bp and 241 bp by the
AciI endonuclease. AciI resistant fragments potentially carrying mutations were cloned into
pCR2.1 TOPO and sequenced. F1 frame shift mutations predicted to truncate the translated
camk2g1 protein were crossed with each other to generate F2 homozygous mutant embryos.
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Crosses between camk2g1 heterozygous adults identified at each generation with the genotyping
method described above were used to maintain the mutant strain population. Mutations were
confirmed by PCR amplification of camk2g1 exon2 followed by sequencing.

Measurement of CaMKII activity
Control, camk2g1 mutants, and embryos injected with the camk2g1 translation blocking
morpholino (MO) were dechorionated and lysed as previously described. Total CaMKII activity
was assessed by measuring phosphate incorporation into autocamtide2, as previously described
(Rothschild et al., 2007).

Morpholino injections
Translation-blocking antisense morpholino oligonucleotide (MO) were used to target zebrafish
camk2g1 and camk2g2. The camk2g1 MO (1ng or 0.5ng) and the camk2g2 MO (10ng) were
previously described and validated (Francescatto et al., 2010; Rothschild et al., 2011; Rothschild
et al., 2013).

Immunofluorescence and Microscopy
Fluorescent and transmitted light micrographs were acquired using a Nikon AZ100 macro zoom
fluorescent stereo microscope. For fluorescent localization, embryos were fixed in 4%
formaldehyde/PBS or Dent’s fixative as previously described (Rothschild et al., 2011). Fixed
embryos were incubated with mouse anti-acetylated -tubulin (Sigma Chemical Co. (T7451) at 2
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g/ml) or mouse anti-1 Na+/K+-ATPase (Developmental Studies Hybridoma Bank, University
of Iowa (6F) at a 1:10 dilution). Primary antibody incubations were overnight and were followed
by either goat anti-mouse Alexa488 or goat anti-rabbit Alexa568 (Invitrogen at 2.5 g/ml).
Embryos were imaged by confocal microscopy (Nikon C2 Plus two-laser) on a Nikon Eclipse Ni
compound microscope using a 20X dry objective or on a Nikon AZ-100 macro zoom fluorescent
stereo microscope using Elements AR 4.50 software.

Quantitative PCR
Embryos were collected from control and camk2g1 mutant embryos at 24 hours post fertilization
(hpf), dechorionated, and total RNA was extracted as previously described (Rothschild et al., 2009;
Rothschild et al., 2007). Concentration and purity of total RNA was assessed using a Nanodrop
1000 spectrophotometer (Thermo Fisher Scientific). cDNA was prepared as previously described
using approximately 1µg of RNA per reaction (Rothschild et al., 2009; Rothschild et al., 2007).
qPCR primers were designed against all seven transcriptionally active CaMKII genes (Table 4.1).
All reactions were performed in triplicate using 2x SensiFAST SYBR No-ROX Mix (Bioline,
BIO-98005). qPCR analysis was performed using a micPCR system (Bio Molecular Systems,
M0000636). Single product amplification was confirmed using both a melt curve and direct
sequencing of the product. Gene expression fold change was analyzed using the 2 -ΔΔCT method and
was normalized to elongation-factor 1-alpha (ef1α) (Silver et al., 2006).
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RT-PCR and Sequencing
Total RNA from control and camk2g1 mutant embryos at 24hpf was prepared as described above.
PCR primers were designed to amplify the variable domain and were used as previously described
(Rothschild et al., 2007). PCR products were cloned into the pSC-A vector (Agilent) and
sequenced to identify CaMKII gene specific splice variants.

Camk2g1 CRISPR/Cas9 G0 embryos
Four guide RNAs (gRNAs) against camk2g1 were designed using the Dharmacon CRISPR design
tool.

Two

were

designed

to

target

the

5’UTR

(CCCGTGACTCTGCTGATTGC,

ATACTACCCATGTAGCTTTG), one was designed to target exon 1 (TGTAACCTCG
ACCAGGTTTA), and one was designed to target exon 2 (GGGGTGCCTTCTCCGTGGTG). The
two gRNAs targeting the 5’UTR region were ordered from the Synthego Corporation using their
CRISPRevolution sgRNA EZ Kit. The gRNAs targeting exon 1 and exon 2 were designed with
the addition of a T7 promoter region (TAATACGACTCACTATA) as well as a constant overlap
region (GTTTTAGAGCTAGAAATAGC). Promega GoTaq Hot Start Green Master Mix (M5122)
with gRNA primers (GCGTAATACG ACTCACTATAG, AAAGCACCGACTCGGT GCCAC),
and

constant

region

oligonucleotides

(AAAAGCACCGACTCGGTGCCACTTTTTC

AAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTA GCTCTAAAAC) were
used to generate the gRNA templates using the following thermocycler conditions: 40 cycles of
95°C for 15 seconds, 60°C for 30 seconds, and 72°C for 20 seconds. The final template was
purified using the GENECLEAN II Kit (MP Biomedicals 1001400). The transcription reaction
was performed using the MEGAshortscript T7 High Yield Transcription Kit (AM1354) with a
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final purification using the RNA Clean & Concentrator Kit (Zymo Research R1015). The four
gRNAs were coinjected at 200ng/l each with Cas9 protein (1ng) (New England Biosciences) into
onecell stage zebrafish embryos. Insertion/deletions were verified by PCR amplification and
sequencing. Primers for camk2g1 5’ UTR (1) (CACTCACTCACACACACAAACAC, CATTTT
AACAATGGGCGAGAG), camk2g1 5’ UTR (2) (GCCACTCTCGCCCATTGTTAAAATG,
CGGGAGGAGAATCTCATGTGGTCC), camk2g1 exon1 (CTCCGTTCTTTCTCTCTCTGG
AC, TACAATGTTGCGCGCACTTAC).

Video Microscopy
Live embryo cilia videos were acquired at 72hpf under differential interference contrast optics
using a Nikon 60X water immersion Plan APO objective and 20 frames per second acquisitions
after transient anesthesia and immobilization in low melting point agarose, as previously described
(Rothschild et al., 2011).

Statistical methods
Statistical analysis used the two-tailed t-test and significance was set at P<0.05.
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Results

Camk2g1 mutants show no gross morphological defects
Camk2g1 mutant embryos were generated by the Thisse lab using TALEN technology
which induced a pre-mature stop codon in exon 2. This stop codon occurred in the catalytic domain
by the addition of 8 nucleotides and the loss of 6, producing an inactive kinase (Figure 4.1 A). The
mutants are homozygous viable through 8 generations. Analysis of gross morphology show no
morphological defects in the camk2g1 mutants when compared to controls (Figure 4.1 B-G). This
is in sharp contrast to previous studies inhibiting camk2g1 activity through the use of morpholinos,
dominant negative, and pharmacological inhibition (Francescatto et al, 2010) (Rothschild et al,
2011) (Rothschild et al, 2013) (Rothschild et al, 2018). Studies using the previously stated methods
resulted in embryos that exhibited defects that include body curvature, hydrocephaly, left-right
asymmetry defects, and kidney abnormalities. Analysis of CaMK-II activity showed 20-30%
decrease in total CaMK-II activity in camk2g1 mutants when compared to controls, demonstrating
successful loss of function in mutant embryos (Figure 4.1 H)

Camk2g1 mutants show no morphological defects when injected with camk2g1 morpholino
The loss of camk2g1 in homozygous mutants causes no morphological defects, in contrast
to previous studies using morpholinos to suppress activity (Francescatto et al, 2010) (Rothschild
et al, 2011) (Rothschild et al, 2013) (Rothschild et al, 2018). In an effort to further validate the
specificity of the camk2g1 morpholino, camk2g1 mutant embryos were injected with 1ng of the
camk2g1 morpholino and morphology was compared to controls, un-injected mutant embryos, and
camk2g1 morphants. As previously reported, camk2g1 mutants produce no morphological defects
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when compared to control embryos (Figure 4.2 A-C, G-I) Camk2g1 morphants exhibit dorsal-axis
curvature, hydrocephaly, and defects in cloacal morphology (Figure 4.2 D-F). The injection of 1ng
of camk2g1 morpholino into camk2g1 mutant embryos showed none of the defects seen in
morphants embryos, with no body curvature present, normal cloaca formation, and no visible brain
defects (Figure 4.2, J-L). Analysis of percent inhibition of CaMK-II activity in camk2g1 mutants
confirm a loss of CaMK-II activity by almost 30%. However, embryos injected with .5ng or 1ng
of camk2g1 morpholino show a greater loss than the camk2g1 mutants. Embryos injected with
.5ng have a 40% loss of CaMK-II activity while embryos injected with 1ng of camk2g1
morpholino have a 60% loss (Figure 4.2 M).

Camk2g1 mutants show no kidney defects when injected with camk2g1 morpholino
Inhibition of camk2g1 caused severe defects in kidney development in zebrafish embryos
that include loss of cell migration, loss ductal convolution, cloacal cilia loss, and the development
of pronephric cysts (Rothschild et al, 2011) (Rothschild et al, 2018). Kidney development was
evaluated in camk2g1 morphants, camk2g1 mutants, and camk2g1 mutants injected with 1ng of
camk2g1 morpholino. Consistent with previous finding, camk2g1 morphants pronephros failed to
convolute and had a significant increase in ear-kidney distance indicating a loss of cellular
migration (Figure 4.3 A-B, E-F, p<.05). Camk2g1 mutant embryos had normal pronephric
development when compared to controls, with over 90% of the embryos having convolution of the
pronephric ducts and an ear-kidney distance equivalent to controls (Figure 4.3 C, E-F, p<.05).
Camk2g1 mutants injected with the camk2g1 morpholino also had normal kidney development,
with convolution in over 90% of embryos and normal kidney cell migration (Figure 4.3 D, E-F,
p<.05) (n=20-35 per condition)
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Cloacal cilia formation and stability was also assessed in camk2g1 morphants, camk2g1
mutants, and camk2g1 mutants injected with 1ng of camk2g1 morpholino. Previous studies have
shown that embryos with suppressed camk2g1 lose cloacal cilia formation and stability and have
cloacal occlusions (Rothschild et al, 2011) (Rothschild et al 2018). Camk2g1 morphants mimicked
previous studies, with a reduction in the number of cloacal cilia from an average of 12 to 2 as well
as significant decrease in the length of remaining cilia (Figure 4.3 G-H, p<.05). Camk2g1 mutants
exhibited no changes in cloacal cilia number or length when compared to controls. This was also
true for camk2g1 mutants injected with the camk2g1 morpholino (Figure 4.3 G-H, p<.05). These
results are consistent with a total loss of camk2g1 in mutant embryos as well as demonstrates the
specificity of the morpholino. (n=20 embryos per condition and n=20-50 cilia per condition)

Genetic Compensation in Camk2g1 Mutants
In an effort to understand the discrepancy between the phenotypes of camk2g1 mutants and
morphants, expression of all 7 CaMK-II genes were assessed using qPCR to look for evidence of
genetic compensation. Validated primer sets were used to assess expression of the 7 CaMK-II
genes in zebrafish at 24hpf in camk2g1 mutants and control embryos. Results showed a 40-90%
decrease in transcript level in camk2a, camk2b1, camk2b2, camk2d1 and camk2d2 while transcript
levels of camk2g2 were increase over 3 fold in camk2g1 mutants (Figure 4.4 A). This increase in
expression of camk2g2 persists at 48hpf as did the decrease in camk2a, camk2b2 and camk2d1
expression (Figure 4.5) This increase in camk2g2 expression was further validated by amplifying
and cloning the variable domains of CaMK-II genes in control and camk2g1 mutant embryos.
Sequencing of obtained clones showed an increase in the presence of clones expressing camk2g2
compared to controls. In addition, clones obtained were both nuclear and cytosolic targeted in both
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control and mutant embryos, with two new camk2g2 splice variants being identified in clones
obtained from camk2g1 mutants. This not only supports the hypothesis of genetic compensation
by camk2g2 in camk2g1 mutants but also provides a potential role of camk2g1 regulation of other
isoforms (Figure 4.4 B-D).
In order to validate the role of camk2g2 compensation in camk2g1 mutants, a morpholino
was used to suppress activity of camk2g2 in wild type embryos and camk2g1 mutants. Embryos
injected with 10ng of the camk2g2 morpholino show no gross morphological defects and had no
defects in left-right asymmetry when compared to controls. However, when camk2g1 mutants
were injected with the camk2g2 morpholino, there was a loss of left-right asymmetry in the
majority of injected embryos (Figure 4.4 E). In addition, wild type embryos injected with the
camk2g2 morpholino showed no defects in ductal convolution, while camk2g1 mutant embryos
injected with the camk2g2 morpholino showed a loss of convolution in over 90% of injected
embryos. Cloacal cilia and ear development were not affected by the injection of the camk2g2
morpholino in either wild type embryos or camk2g1 mutants (Figure 4.4 F). These results
demonstrate the new-found roles of camk2g2 in camk2g1 deficient embryos.

Camk2g1 CRISPR Mutants Phenocopy Camk2g1 Morphants
As camk2g1 mutants develop normally, CRISPR/Cas9 technology was used in an attempt
to study camk2g1 roles in development. Four non-overlapping guide RNAs were designed to target
camk2g1. Two were designed to target the 5’UTR. One was designed to target exon1 and the last
was designed to target exon2 (Figure 4.6 A). The efficacy of the four designed gRNA were
confirmed by sequencing (Figure 4.7). Embryos injected with the 4 guide RNAs exhibited a variety
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of phenotypes as would be expected from mosaic expression. However, the majority of injected
embryos exhibited developmental defects that mimicked camk2g1 morphants. These include tail
curvatures, brain defects, and smaller otoliths (Figure 4.6 B-G). In addition, kidney cyst were
visible in approximately 50% of injected embryos by 48hpf (Figure 4.6 E).
Expression of all 7 CaMK-II zebrafish genes were assessed in embryos injected with the 4
guide RNAs targeting camk2g1 using qPCR. The same validated primer set was used as previously
described (Table 4.1). Analysis of CaMK-II expression in CRISPR mutants shows a statistically
significant decrease in the presence of both camk2b1 and camk2g1 and a statistically significant
increase in camk2a expression (Figure 4.6 H) In contrast to camk2g1 mutants, there was no
statistically significant difference in expression of camk2g2 in CRISPR mutants (Figure 4.6 H).
This supports the hypothesis that it is the increase in camk2g2 expression in camk2g1 mutants that
is able to compensation for the absence of its paralog gene, and that this compensation is not
occurring in embryos mosaically expressing the 4 CRISPR guide RNAs.

Camk2g1 CRISPR mutants exhibit kidney defects that phenocopy Camk2g1 morphants
In an effort to further understand the development of camk2g1 CRISPR mutants, kidney
development was assessed by observing ductal convolution, cell migration, and cloacal defects
commonly seen in camk2g1 morphants (Rothschild et al, 2011) (Rothschild et al, 2018).
Approximately 80% of camk2g1 CRISPR mutants pronephric ducts failed to convolute, with
branching occurring in a subset of embryos (Figure 4.8 A-D). Kidney cell migration was also
inhibited in camk2g1 CRISPR mutants, demonstrated by the statistically significant increase in
ear-kidney distance in mutants when compared to control (Figure 4.8 E, p<.05). Cloacal cilia were
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also affected in mutants, with an average decrease in cloacal cilia present from approximately 11
cilia in controls (Supplemental Video 4.1) to 5 cilia in mutants, with some possessing no cloacal
cilia at all (Supplemental video 4.2) (Figure 4.8 F-I, p<.05). Although the number of cloacal cilia
present was significantly reduced in camk2g1 CRISPR mutants, the length of remaining cilia were
unchanged when compared to controls (Figure 4.8 J). This is likely due to the mosaic expression
in camk2g1 CRISPR mutants. Ductal cilia were unaffected in camk2g1 CRISPR mutants when
compared to controls (Supplemental Video 4.3 and 4.4). The kidney defects seen in CRISPR
mutants phenocopies that of camk2g1 morphants, further supporting the specificity of the
morpholino as well as validating the morphants phenotype seen in current and previous studies.
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Discussion
CaMK-II is a serine/threonine protein kinase encoded by 4 genes in humans (α, β, γ, δ) and
7 in zebrafish (α, β1, β2, γ1, γ2, δ1, δ2). (Tombes et al, 2003) (Rothschild et al, 2009) It is present
in virtually all tissue types and is known to be involved in variety of cellular functions, from long
term potentiation to ion channel regulation (Hudman and Schulman, 2002). Through the use of
knockdown mechanisms such as morpholinos, dominant negatives, and pharmacological
inhibition, roles of CaMK-II have been expanded to include kidney morphogenesis, left-right
asymmetry, and inner ear development (Francescatto et al, 2010) (Rothschild et al, 2011)
(Rothschild et al, 2018). Further studies into the roles of CaMK-II would benefit from the
development of a stable mutant line in zebrafish. However, this has proven difficult, with some
CaMK-II genes, namely camk2g1, proving to be resistant to mutations. (Gagnon et al, 2014).
In this study, a camk2g1 mutant was generated in zebrafish using TALEN genomic editing.
Although the use of TALENs was successful in generating a premature stop codon in exon 2 of
camk2g1, embryos developed normally, with no sign of the defects seen using the previously
mentioned knockdown mechanisms. This study was able to identify genetic compensation as a
potential cause for the lack of phenotype in these embryos through the upregulation of a paralog
gene. It also identified a potential new role for camk2g1 as a regulator for other CaMK-II genes
expression during development. In addition, this study was also able to validate previous finding
on the role of CaMK-II though validation of the previously used camk2g1 morpholino.
Camk2g1 mutants possess an over three fold increase of the camk2g1 paralog camk2g2.
Previous publications have described the evolutionary retention of these genetic paralogs and
redundant (El-Brolosy and Stainier, 2017). However, this terminology implies an almost
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unnecessary role for these paralogs. The ability of ‘redundant’ genes to compensate for the loss of
their paralog provides a compelling argument for their evolutionary retention. In the current study,
the increased expression of camk2g2 in camk2g1 mutants seems to prevent the severe phenotypic
defects seen in morphants, giving a more defined purpose to its evolutionary retention.
Genetic compensation has also been termed “transcriptional adaptation” (El-Brolosy and
Stainier, 2017). Exactly how the loss of one gene induces compensation of its paralog or a similar
gene is currently unknown but several pathways have been suggested that include a variety of
potential signaling partners including chromatin remodelers, transcription factors, and RBPs (ElBrolosy and Stainier, 2017). Deciphering exactly how transcriptional adaptation occurs requires
further study. However, genetic knockdown methods are known to not induce genetic
compensation, it would seem that the presence of mutant mRNA is necessary to induce
transcriptional adaption either through direct contact with its paralog, or though other epigenetic
mechanisms.
In addition for providing evidence of genetic compensation in camk2g1 mutants, this study
also supports the use of genetic knockdown methods in developmental studies. Currently,
knockout methods such as TALEN and CRIPSR/Cas9 are almost required parts of any
developmental biology study. However, there have been a large number of phenotypic
discrepancies between mutants and morphants in mice, zebrafish, and cell culture (Kok et al, 2015)
(Daude et al, 2012) (Karakas et al, 2007). This had led to a distrust in results derived from studies
using knockdown methods such as morpholinos. It had been suggested that mutants provide a more
accurate depiction of the roles of a gene of interest and that many of the phenotypes derived from
knockdown methods are produced from off target effects.
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This study in combination with other published works provides evidence that for some
genes, morpholinos may provide a more accurate phenotype than their mutant counterparts.
Research have shown that some genes, like camk2g1, can be resistant to mutations (Gagnon et al,
2014). In addition, the upregulation of camk2g2 in camk2g1 mutants seems to prevent the
development of the expected morphant phenotype (Rothschild et al, 2011) (Rothschild et al, 2018).
This upregulation of paralogs or other genetic family members has been seen in other studies where
mutants and morphants did not possess the same phenotype (Rossi et al, 2015) (She et al, 2019).
Therefore, it is likely that genetic compensation can account for many of the differences seen
between morphant and mutants for genes of interest. If this is the case, then embryos that do not
exhibit compensation, i.e. morphants, may provide a more accurate picture for the roles of a
particular gene than the mutant in some cases.
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Figure 4.1. Characterization of camk2g1 mutant zebrafish. Electropherograms of exon2 of
camk2g1 in wild type and camk2g1 “TALEN” mutant embryos show a loss of 8 nts and gain of 6
nts leading to a premature stop codon (A). Camk2g1 mutants appear phenotypically normal at 22s
(B, C), 48hpf (D, E) and 4dpf (F,G). CaMKII specific activity (nmoles/min/mg) is reduced by 2530% at 48hpf and 72hpf in camk2g1 mutants when compared to controls (H).
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Figure 4.2. Camk2g1 mutants injected with camk2g1 MO develop normally. Control, camk2g1
morphants, camk2g1 mutants, and camk2g1 mutants injected with 1ng of the camk2g1 MO were
imaged at 48hpf (A-L). Camk2g1 morphants display curved tails (B) smaller otoliths (F) and
defects in cloacal morphology (J). Control embryos, camk2g1 mutants, and camk2g1 mutants
injected with the camk2g1 MO do not display such morphological defects. CaMKII activity assays
of 72hpf embryos reveal twice the reduction in CaMKII activity in camk2g1 morphants injected
with 0.5ng or 1.0ng of camk2g1 MO, when compared to camk2g1 mutants (M).
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Figure 4.3. Normal kidney development in camk2g1 mutants injected with the camk2g1 MO.
Anterior convolution was assessed at 72hpf in control, camk2g1 morphants, camk2g1 mutants, and
camk2g1 mutants injected with camk2g1 morpholino by immunostaining the kidney specific
NaKATPase (A-D). Quantification of convolution in the anterior pronephric duct (E). Analysis of
cellular migration at 72hpf in the pronephric duct by measuring the distance between the posterior
ear and anterior kidney (F). Cloacal cilia number (G) and length (H) were assayed at 72hpf.
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Figure 4.4. Molecular and Functional Compensation of camk2g1 mutants by camk2g2. qPCR
of CaMK-II genes in camk2g1 mutants at 24hpf relative to ef1α (A). Percentage of clones
attributed to each CaMK-II gene after amplification and sequencing of variable domains in control
and camk2g1 mutants at 24hpf (n=15-18) as previously described (B) (Rothschild et al., 2007).
CaMK-II splice variant exon utilization falls into specific categories (C) (Rothschild et al., 2007).
CaMK-II splice variants denoted by gene and categories that were observed in control and
camk2g1 TALEN mutant embryos. Previously unreported splice variants of camk2g2 are colored
red (D). Cardiac asymmetry was evaluated at 24hpf by live embryo observation under indicated
conditions (E). Convolution was assessed by examining immunostained embryos using the kidney
specific NaKATPase (F).
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Figure 4.5. Relative mRNA Fold Change at 48hpf in camk2g1 Mutants. Relative fold change
of CaMK-II genes in camk2g1 mutants relative to ef1α. Camk2g2 shows a statistically significant
increase in expression in camk2g1 mutants. Camk2b2, camk2d1, and camk2a show a statistically
significant decrease in expression in camk2g1 mutants.
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Figure 4.6. Morphological Defects in camk2g1 CRISPR Embryos. 4 gRNAs were designed
against camk2g1 to generate G0 camk2g1 CRISPR embryos (A). G0 camk2g1 CRISPR embryos
show variable phenotypes with shortened anterior posterior axis and tail curvatures evident at
48hpf (C) compared to control embryos (B). Kidney cysts develop by 48hpf (E, asterisks) and
were absent in control embryos (D). Otoliths were smaller in camk2g1 CRISPR embryos when
compared to controls (F, G). Dorsal, anterior to the left (D, E). Lateral, anterior to the left (F, G).
qPCR of CaMK-II genes in camk2g1 CRISPR embryos at 24hpf relative to ef1α
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Figure 4.7. Genomic confirmation of camk2g1 CRISPR embryos. Twenty pooled embryos
were sequenced using the sense primer for each of the four gRNA target sequences.
Electropherograms for control and camk2g1 CRISPR embryos confirmed insertion/deletions of
each gRNA target.
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Figure 4.8. Kidney defects in camk2g1 CRISPR embryos. Anterior convolution is reduced in
camk2g1 CRISPR embryos compared to controls at 72hpf (A-D). The ear-kidney distance is
increased in camk2g1 CRISPR embryos at 72hpf (E). Cloacal cilia number is reduced in camk2g1
CRISPR embryos (F-I). However, length of remaining cloacal cilia in camk2g1 CRISPR embryos
is unchained when compared to control embryos (J).
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Supplemental Video 4.1. Control embryos have beating cloacal cilia at 72hpf. Shown at 20
frames per second.
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Supplemental Video 4.2. Camk2g1 CRISPR embryos lack beating cilia at 72hpf. Shown at 20
frames per second.
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Supplemental Video 4.3. Control embryos have beating ductal cilia at 72hpf. Shown at 20
frames per second.
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Supplemental Video 4.4. Camk2g1 CRISPR embryos have ductal cilia beating at 72hpf.
Shown at 20 frames per second.
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Gene Primer
S camk2a
AS camk2a
S camk2b1
AS camk2b1
S camk2b2
AS camk2b2
S camk2g1
AS camk2g1
S camk2g2
AS camk2g2
S camk2d1
AS camk2d1
S camk2d2
AS camk2d2

(5’ – 3’)
GTCGCAGGATCAGTCGTTTGAG
GCAACAGCAAAGTGGCTTCATC
GCTCTCCAAGAACAGTAAGCCC
GACATTCTGCCATTTGGAGTCC
GAACAGTAAACCGATCCACACC
GAGCAGTGGAAGTGAATGTTCTG
GCCTGGATTCTCGAGATAATGG
CTCCCGTTGGTCAAAGATTGGAC
GATGCTGCATGCTTCTAATGTC
GTTTCAAACCTCCACCTCTACC
CAGCTGAGCTTCAACAAGTGTC
CTGAAATGATTCTCCAGCTCTC
GGAGAAACCATCAGCAAAAACC
CTTGAACTCTCTGGTCCATGTG

Table 4.1 qPCR Primers. Primers targeted for the 7 CaMK-II in zebrafish for amplification in
qPCR. All primers were designed to target the 3’UTR except camk2b1 and camk2b2 which were
designed to target the association domain.
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Chapter 5: Reduction of camk2g1 Activity in Zebrafish Reveal Novel Roles of CaMK-II in
Kidney Morphogenesis that may be Imperceptible in Mutant Models Due to Genetic
Compensation.

Since their initial use as a model organism in the 1970s, zebrafish have emerged as an
essential tool for developmental studies and disease modeling. Their quick developmental time,
high rate of gene conservation with humans, and relatively low husbandry cost have enabled
zebrafish to be used in a variety of different research fields. For this study, which focuses on kidney
development and ADPKD modeling, their transparency during development has enabled real time
imaging of pronephric development and the identification of potential therapeutic targets for
ADPKD patients.
Previous research identified CaMK-II, a serine/threonine protein kinase, as a downstream
target of Ca2+ flux though the cation channel formed by PKD2, one the genes most commonly
mutated in ADPKD patients. Once activated, CaMK-II acts to regulate a number of pronephric
developmental processes including cell migration, ductal convolution, and cloacal cilia
development and stability. Inhibition of camk2g1, the predominant form of CaMK-II in the
zebrafish kidney, not only disrupts the previously mentioned processes, but also causes the
development of anterior kidney cysts. The addition of a constitutively active form of CaMK-II was
able to inhibit cyst development, as well as prevent other pronephric defects seen in camk2g1
morphants.
This study expands upon the previously established role of CaMK-II in pronephric
development by identifying its regulation of histone deacetylase 4 (HDAC4) as necessary for
kidney morphogenesis. Histone deacetylases are known regulators of gene transcription whose
presence in the nucleus causes the condensing of chromatin, preventing transcription of its target
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genes. In in study, hdac4 was localized predominantly in the cytosol during pronephric
development. The suppression of camk2g1 caused the subcellular translocation of hdac4 from the
cytosol to the nucleus, thereby preventing transcription of genes normally active during
organogenesis. Co-inhibition of hdac4 was able to rescue ductal convolution defects seen in
camk2g1 morphants, identifying histone deacetylases as a potential new target for treatments for
ADPKD. However, caution should be used as suppression of hdac5 exacerbated defects in
camk2g1 morphants.
Further studies into this pathway should focus on identifying other downstream targets.
Potential targets identified by this study include notch signaling proteins. Inhibition of camk2g1
caused the loss of the notch response element tp1 in the cloaca and the increase in expression of
the notch ligand deltaC. Similar to earlier studies, the expression of deltaC could be rescued in
camk2g1 morphants with suppression of hdac4 suggesting that notch signaling proteins may be
downstream members of that pathway, and a potential target for treatments for ADPKD. Future
studies should focus on understanding the connections between these pathways by analysis of other
notch signaling proteins in camk2g1 morphants, such as notch3 and jagged2 in order to identify
specifically what notch proteins are being affected.
In addition to identifying the regulation of HDAC4 by CaMK-II, this study also further
demonstrates the multifactorial roles of CaMK-II during kidney development. Inhibition of hdac4
was able to rescue ductal convolution in camk2g1 morphants, but it was unable to rescue cell
migration. This suggests that the processes of ductal convolution and cell migration are separate
and that CaMK-II plays an integral role in both pathways. Pronephric cells migrate at a slower
rate in camk2g1 morphants when compared to controls, never reaching the site where they should
convolute inward to connect with the glomerulus. In an effort to understand this reduction in
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cellular migration rate, this study has identified two potential causes for this defect. One is the
increase in expression of the extracellular matrix protein collagen. In camk2g1 morphant,
expression of the ECM protein col2a1a was increased, mimicking the expression previously seen
in pkd2 morphants. Increase in collagen expression may be a potential cause for the decreased
migration as increased collagen expression is associated with reduced migratory capabilities,
caused by an increase in focal adhesion attraction to the ECM. This is also supported by the partial
rescue of convolution seen in camk2g1 morphants treated with the secretory inhibitor, Brefeldin
A (BFA). Future research into this area would benefit from the analysis of kidney specific collagen
protein as well as well as more specific mean of inhibiting collagen secretion as BFA inhibits all
COP II dependent secretory pathways and is likely inhibiting other necessary pathways.
This research, as well as previous studies, has relied heavily upon the use of knockdown
mechanisms such as morpholinos, dominant negatives, and pharmacological inhibitors. Currently,
the generation of genetic mutants has become a new standard for developmental research. A
mutant for camk2g1 was generated in zebrafish using TALENs. However, the mutants displayed
none of the defects seen in previously studies using knockdown methods. This occurrence is not
unique to this study, as there have been many other previously reported discrepancies between
mutants and morphants in various model organisms. In this case, genetic compensation seems to
be the cause of the lack of phenotype in camk2g1 mutants. qPCR analysis of the 7 CaMK-II genes
present in zebrafish identified a 3 fold increase in the expression of the camk2g1 paralog, camk2g2
in mutants when compared to controls, preventing any defects caused by the loss of camk2g1. This
study also demonstrated that compensation by a paralog gene is not an immediate occurrence, as
G0 camk2g1 CRISPR embryos did not display the same increase in camk2g2 expression and
possessed nearly all of the morphological defects seen previously in camk2g1 morphants. These
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results support the findings of previous studies using knockdown mechanisms such as
morpholinos, as genetic compensation may occur in mutant models, inhibiting any reverse genetic
studies. Future studies should focus on using the compensatory ability of CaMK-II paralogs to
determine how and when compensation in initiated. Generational studies with stable lines
generated with the 4 gRNAs for camk2g1 could be used in conjunction with qPCR analysis to
determine if compensation by camk2g2 is initiated with the first stable generation or if it is
developed over several generations.
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